<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-id journal-id-type="pmc-domain-id">2873</journal-id><journal-id journal-id-type="pmc-domain">ncomms</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11111456</article-id><article-id pub-id-type="pmcid-ver">PMC11111456.1</article-id><article-id pub-id-type="pmcaid">11111456</article-id><article-id pub-id-type="pmcaiid">11111456</article-id><article-id pub-id-type="pmid">38778053</article-id><article-id pub-id-type="doi">10.1038/s41467-024-48719-x</article-id><article-id pub-id-type="publisher-id">48719</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Controlled oxygen delivery to power tissue regeneration</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zoneff</surname><given-names initials="E">Elizabeth</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6082-8721</contrib-id><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6150-3822</contrib-id><name name-style="western"><surname>Jackson</surname><given-names initials="C">Colin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0005-6774-5837</contrib-id><name name-style="western"><surname>Smith</surname><given-names initials="O">Oliver</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Duchi</surname><given-names initials="S">Serena</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Onofrillo</surname><given-names initials="C">Carmine</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Farrugia</surname><given-names initials="B">Brooke</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8320-3852</contrib-id><name name-style="western"><surname>Moulton</surname><given-names initials="SE">Simon E.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3831-8738</contrib-id><name name-style="western"><surname>Williams</surname><given-names initials="R">Richard</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8212-9884</contrib-id><name name-style="western"><surname>Parish</surname><given-names initials="C">Clare</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1343-0769</contrib-id><name name-style="western"><surname>Nisbet</surname><given-names initials="DR">David R.</given-names></name><address><email>david.nisbet@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Caballero-Aguilar</surname><given-names initials="LM">Lilith M.</given-names></name><address><email>l.caballeroaguilar@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>The Graeme Clark Institute, </institution><institution>The University of Melbourne, </institution></institution-wrap>Parkville, Melbourne, VIC Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Biomedical Engineering, Faculty of Engineering and Information Technology, </institution><institution>The University of Melbourne, </institution></institution-wrap>Parkville, Melbourne, VIC Australia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.1001.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 7477</institution-id><institution>Research School of Chemistry, </institution><institution>Australian National University, </institution></institution-wrap>Canberra, ACT Australia </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.1001.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 7477</institution-id><institution>ARC Centre of Excellence in Synthetic Biology, </institution><institution>Australian National University, </institution></institution-wrap>Canberra, ACT Australia </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Surgery, Faculty of Medicine, Dentistry and Health Science, </institution><institution>The University of Melbourne, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/001kjn539</institution-id><institution-id institution-id-type="GRID">grid.413105.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 8606 2560</institution-id><institution>Aikenhead Centre for Medical Discovery, </institution><institution>St. Vincent&#8217;s Hospital, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/031rekg67</institution-id><institution-id institution-id-type="GRID">grid.1027.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0409 2862</institution-id><institution>Department of Engineering Technologies, </institution><institution>Swinburne University of Technology, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/031rekg67</institution-id><institution-id institution-id-type="GRID">grid.1027.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0409 2862</institution-id><institution>Iverson Health Innovation Research Institute, </institution><institution>Swinburne University of Technology, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02czsnj07</institution-id><institution-id institution-id-type="GRID">grid.1021.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0526 7079</institution-id><institution>IMPACT, School of Medicine, </institution><institution>Deakin University, </institution></institution-wrap>Geelong, VIC Australia </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>The Florey Institute, </institution><institution>The University of Melbourne, </institution></institution-wrap>Melbourne, VIC Australia </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Melbourne Medical School, Faculty of Medicine, Dentistry and Health Science, </institution><institution>The University of Melbourne, </institution></institution-wrap>Melbourne, VIC Australia </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">452197</issue-id><elocation-id>4361</elocation-id><history><date date-type="received"><day>7</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>23</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-24 00:25:13.280"><day>24</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41467_2024_Article_48719.pdf"/><abstract id="Abs1"><p id="Par1">Oxygen plays a crucial role in human embryogenesis, homeostasis, and tissue regeneration. Emerging engineered regenerative solutions call for novel oxygen delivery systems. To become a reality, these systems must consider physiological processes, oxygen release mechanisms and the target application. In this review, we explore the biological relevance of oxygen at both a cellular and tissue level, and the importance of its controlled delivery via engineered biomaterials and devices. Recent advances and upcoming trends in the field are also discussed with a focus on tissue-engineered constructs that could meet metabolic demands to facilitate regeneration.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">This review explores the role of oxygen and its delivery via engineered biomaterials in a plethora of physiological processes. This piece emphasises on the application of advanced oxygen delivery strategies, as well as discussing advances in oxygen-generating materials and oxygen-perfusing devices.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Drug delivery</kwd><kwd>Biomaterials - proteins</kwd></kwd-group><funding-group><award-group><funding-source><institution>Australian Research Council</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">The base unit of the body are cells, and cells require energy. As tissues and organs become more complex, the utilities that ensure their metabolic demands are met increase in capacity and sophistication. A challenge hindering the translation of tissue engineering and regenerative medicine into clinical practice is ensuring an engineered solution for the mass transport of nutrients and molecular oxygen to cells.</p><p id="Par4">For engineered tissues, the size of the bioengineered tissue that can be fabricated ex-situ or in situ is limited by poor oxygen transport from physiological environments into newly implanted constructs. In the absence of a vascular system, a reliance on the diffusion of molecules throughout bioengineered tissues or bioscaffolds might not be rapid enough to satisfy the vital oxygen demand<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Challenges arise when trying to control oxygen tension, as it decreases towards the center of the graft or bioscaffold. Over time, the effects of hypoxia and accumulation of waste products, can culminate in central cell death, resulting in a necrotic core<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>.</p><p id="Par5">Mimicking the complex geometries of the vascular network and achieving complete integration with host tissue is a vital future step towards truly engineered tissue. This is because it not only enables the distribution of oxygen, but also facilitates enhanced nutrient exchange and removal of metabolic waste. Efforts to replicate the host tissue vasculature involve stimulating blood vessel in-filtration into the tissue through growth factor up-regulation and/or supplementation and/or fabricating perfusable template channels that can direct endothelial progenitors to form organized vascular networks<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. However, not only do these require time to mature, but incomplete angiogenesis is also associated with ischemic conditions, and the fragile networks observed from overvascularisation can be similarly detrimental<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par6">Oxygen is transported from gases within the alveola to tissues by hemoglobin. Inspired by this, an alternative approach is the development of oxygen-generating biomaterials and devices that have the potential to provide a depot of oxygen species to replenish oxygen on demand. For instance, tissue scaffolds that have been functionalised with peroxides and perfluorocarbons show evidence of controlled and prolonged oxygen delivery (&gt;12 days in vitro)<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Although there remain several challenges that need to be addressed before oxygen-generating biomaterials can become clinically widespread, recent developments are exceptionally promising&#160;Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>The key role of oxygen in driving tissue regeneration is an interplay between biological considerations, delivery from biological molecules and chemicals, and the delivery strategy.</title><p>Organogenesis and biological processes can be classified according to the developmental stage (pre-natal and post-natal), with events such as tissue regeneration occurring at the post-natal stage. Delivery strategies can be device- or material-dependent, with some strategies overlapping these two. Molecules and chemicals that produce oxygen can be naturally derived (organic) or inorganic (such as peroxides). Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e383" position="float" orientation="portrait" xlink:href="41467_2024_48719_Fig1_HTML.jpg"/></fig></p><p id="Par7">In this review, we explore the fundamental biological role of oxygen and subsequently focus on past and current efforts to deliver oxygen to engineered tissues for regeneration to alleviate the limitations of passive diffusion. Both biological and non-biological approaches to oxygen delivery are considered, and the future scope of both biomolecule engineering and materials engineering are discussed in this context.</p></sec><sec id="Sec2"><title>The pivotal role of oxygen in mammalian events</title><p id="Par8">Oxygen regulation undergoes dynamic adjustments throughout embryogenesis and maturation events. Through the years, the study of physiological processes has provided stepping stones in understanding how oxygen is regulated from the cellular level to organogensis and tissue repair. The understanding of this sophisticated relationship between tissue development and oxygen has led to new evidence-based clinical practices; for example, during embryonic development, there has been a shift from the previously endorsed low oxygen tension (5% O<sub>2</sub>, or 38&#8201;mmHg)<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup> due to recent contrasting evidence<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. This example underscores the need for ongoing exploration and understanding of oxygen&#8217;s role in key events such as cellular respiration, hypoxia, development, tissue damage, and repair. We provide a brief introduction to these events in the following subsections.</p><sec id="Sec3"><title>Function of oxygen in development</title><p id="Par9">Oxygen is tightly regulated through human development and adult homeostasis. First identified in the 1970s, the link between mammalian embryogenesis and oxygen levels encompasses two primary phases. Initial low oxygen levels (8&#8211;38&#8201;mmHg) support embryogenesis, promoting cell proliferation and maintain embryonic cells in an undifferentiated state (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). This phase is guided by hypoxia-inducible factors (HIF) and transcription genes like vascular endothelial growth factor (VEGF). Oxygen levels then rise almost 2-fold after placental formation, optimizing maternal-fetal oxygen and nutrient transfer and securing adequate oxygen delivery to the growing organism<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Oxygen in development and HIF-1<italic toggle="yes">&#945;</italic> regulation.</title><p><bold>a</bold> The role of oxygen in development starts from embryonic development up to post-natal phase. Early hypoxic conditions trigger HIF1-a accumulation, thus targeting genes associated with vascularization (such as VEGF) to encourage organ formation and placental-fetus interactions. After the placenta is formed, oxygen levels rise up to 38 mmHg. <bold>b</bold> During normoxia, HIF-1a is regulated by prolyl hydroxylation. The HIF1-a subunits contain three sites for hydroxylation (two on prolyl residues within the oxygen-dependent degradation domain (ODDD) and one on an asparaginyl residue within the C-terminal transactivation domain (C-TAD)). Upon oxygen-dependent Fe(II)-, oxygen-, and 2-oxoglutarate, PHDs facilitate prolyl hydroxylation. This is then recognized by the von Hippel-Lindau protein (pVHL), which then marks it for degradation through a process called ubiquitination, leading to its breakdown by the proteasome. Separately, the asparaginyl hydroxylation process is driven by an enzyme called factor-inhibiting HIF (FIH) acting on a specific site in the C-TAD. In hypoxia, when the hydroxylation is suppressed or PHDs are inhibited, HIF-1a is translocated into the nucleus, where it heterodimerises with HIF1-b subunit allowing binding to hypoxia-response elements (HREs). Adapted from<sup><xref ref-type="bibr" rid="CR124">124</xref></sup>. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e438" position="float" orientation="portrait" xlink:href="41467_2024_48719_Fig2_HTML.jpg"/></fig></p><p id="Par10">During early post-natal development, aerobic respiration is the primary oxygen source, with the respiratory system facilitating oxygen transport to organs and tissues at various degrees. Oxygen levels fluctuate between 7.5 and 100 mmHg in mature and healthy mammalian tissues<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Hypoxia and hyperoxia significantly influence development, and dysregulation of the oxygen gradients can hinder organogenesis<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, with imbalances leading to potential developmental challenges<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, respiratory issues<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, low birth weight<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and impairments in cerebrovascular function and neurogenesis<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. This highlights the delicate balance between oxygen-driving gradients and tissue homeostasis.</p></sec><sec id="Sec4"><title>Oxygen upon tissue damage and its role in repair</title><p id="Par11">The immediate response of mature tissue to injury involves immune cell activation and increased blood flow to the injury site. Oxygen is a cornerstone of cellular activities associated with regeneration: (i) in the proliferation phase, it is required for glycoprotein biosynthesis<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and (ii) during the maturation or remodeling phase, it is required as a co-factor for hydroxyproline (key to forming fibrillar collagens)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. The enzymes that are essential for collagen stability, prolyl and lysyl hydroxylases, utilize oxygen as a co-substrate, after hydroxylation, the hydroxylysine residues undergo oxygen dependent- glycosylation, which facilitates cross-linking between collagen molecules. An imbalance of oxygen during the hydroxylation process can lead to unstable collagen formation (for more information about this process, refer to: ref. <sup><xref ref-type="bibr" rid="CR22">22</xref></sup>). In the repair of tissue that relies heavily on collagen formation and where the oxygen tension is lower than in other tissues, such as in cartilaginous tissue, the role of available oxygen may be critical<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Failure to repair can open the path for degenerative diseases and chronic pain.</p><p id="Par12">After injury resolution, the healing-promoting inflammatory microenvironments typically return to homeostasis. However, persistent stimuli can escalate acute inflammation towards a chronic state, potentially leading to degenerative diseases<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Inflammation can paradoxically induce hypoxia (despite the increased demand for oxygen following an injury), a cycle frequently seen in ischemic injuries, where inflammation is both accompanied and triggered by hypoxia<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. Injury-driven hypoxia is common in ischemic injuries, blood vessel damage and thrombotic scenarios.</p><p id="Par13">In diseases characterized by prolonged inflammation, severe oxygen deprivation can occur in affected tissues. For example, in inflammatory bowel disease, the intestinal epithelial cells undergo an inflammatory-induced hypoxia<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. In such hypoxic scenarios, HIFs, which are mediators acting through post-translational hydroxylation of proline residues via prolyl hydroxylase (PHD) enzymes, stabilize by translocating to the cell nucleus where they bind hypoxia response elements (HREs)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2)</xref>. Indeed, recent studies have demonstrated that HIF stabilization through targeted PHD inhibition is an emerging strategy to treat diseases like inflammatory bowel disease.</p></sec><sec id="Sec5"><title>The challenge of providing oxygen to cells for tissue repair</title><p id="Par14">In native tissues, oxygen distribution is guided by structured capillary networks, creating gradients that cater to the varying blood and oxygen demands of different organs. As a result, some are avascular while others are highly vascularized<sup><xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref></sup>. In bioengineered tissues, mimetics of native oxygen gradients remain under investigation. Two key challenges are (i) the lack of interconnection between an engineered vasculature and the host tissue and (ii) the absence of an adequate oxygen supply post-implantation. The limited oxygen diffusion length from native capillaries (typically ~100&#8211;200&#8201;&#956;m)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, often constrains oxygenation of cells nestled deep within newly implanted scaffolds. This problem aggravates within large scaffolds, thereby limiting the reach of tissue engineering constructs in repairing large defects<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par15">However, straightforward augmentation of oxygen supply in the constructs will not yield a sustainable general solution because high concentrations of oxygen (hyperoxia) can inadvertently lead to ROS overproduction<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Cellular oxygen demand also varies among cell types. For example, the oxygen demand of hepatocytes (rate of consumption 0.3&#8201;nmol/s/10<sup>6</sup>) has been reported to be up to 5-fold higher than that of fibroblasts (rate of consumption 0.05&#8201;nmol/s/10<sup>6</sup>) due to their high metabolic activity<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. In addition, this oxygen-metabolic dependent demand fluctuates according to the cell&#8217;s cycle phase (e.g., stromal vs terminally differentiated)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and the cell number within the scaffold<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. The interplay of hypoxia and hyperoxia introduces another layer of complexity to tissue engineering. Short bursts of hyperoxia have been shown to protect against hypoxic damage, a phenomenon termed &#8217;ischemic preconditioning&#8217;<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. This compensatory mechanism, however, has a narrow therapeutic window as prolonged exposure remains detrimental. Thus, oxygen delivery in the context of tissue engineering must optimize oxygen levels to meet cellular demands while navigating the delicate balance between hypoxia and hyperoxia.<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Oxidative phosphorylation, ROS generation, pathology, and redox signaling.</title><p><bold>a</bold> During oxidative phosphorylation, electron carriers NAD+ and FAD feed electrons to the ETC at either complex I or II. The electrons are shuttled through four membrane-bound protein complexes, referred to as complexes I-IV, which undergo a series of redox reactions. Through this process electrons from complexes I and II also enter the `Q-cycle', where they are passed to another electron carrier, ubiquinone (Q), to facilitate transfer to cytochrome c (via complex III as an intermediary). Diatomic oxygen binds to Complex IV, where it accepts the electrons carried by cytochrome C and is reduced to water. Energy released through these reactions facilitates an electrochemical proton gradient, or mitochondrial membrane potential, within the intermembrane space. To relieve this membrane potential, protons can reenter into the mitochondrial matrix through another protein complex, ATP synthase, which harnesses the mechanical energy generated by the movement of protons to overcome energy constrictions limiting the conversion of adenosine diphosphate (ADP) into ATP. &#8220;Leaky" electrons result in the generation of ROS. Adapted from ref. <sup><xref ref-type="bibr" rid="CR125">125</xref></sup>. <bold>b</bold> Oxygen is involved in both redox signaling and pathology in the form of ROS. A number of sources, both endogenous and exogenous, are capable of generating cellular ROS. H<sub>2</sub>O<sub>2</sub> is involved in the signal transduction of pathways that control cell growth, proliferation, apoptosis, and differentiation. However, most ROS species, particularly HO&#8226;-, facilitate oxidative stress, cell damage, inflammation and, subsequently, disease. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e585" position="float" orientation="portrait" xlink:href="41467_2024_48719_Fig3_HTML.jpg"/></fig></p></sec></sec><sec id="Sec6"><title>Biological molecules as oxygen-controlling strategies</title><p id="Par16">The term &#8220;biomolecule" refers to any molecule that is naturally derived from an organism, including, but not limited to, proteins, peptides, nucleic acids and their derivatives, fatty acids, and lipids. In recent years, tissue engineering has focused on developing and identifying materials that can stabilize and provide controlled release of various biomolecules in support of grafted cells or to elicit a desired response from host tissue. The most proven biomolecules in this context are hemoproteins, which can reversibly bind oxygen, and other proteins involved in intracellular oxygen regulation, such as those that scavenge ROS.</p><sec id="Sec7"><title>Hemoglobin and hemoglobin-engineered molecules</title><p id="Par17">Hemoglobin is the most widely recognized oxygen-binding biomolecule because of its role in respiration. It is expressed in red blood cells (RBCs), where it binds oxygen in the lungs and circulates throughout the body via the bloodstream, releasing oxygen in tissue capillaries<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p><p id="Par18">Hemoglobin functions as a heterotetramer (a protein complex with four non-identical subunits) that consists of two <italic toggle="yes">&#945;</italic><italic toggle="yes">&#946;</italic> dimers (<italic toggle="yes">&#945;</italic>1<italic toggle="yes">&#946;</italic>1, <italic toggle="yes">&#945;</italic>2<italic toggle="yes">&#946;</italic>2). Each subunit coordinates one heme cofactor at an identical coordination site, so every functional hemoglobin complex can reversibly bind up to four oxygen molecules simultaneously (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>General biochemical and redox properties of globins and delivery strategies.</title><p><bold>a</bold> The oligomeric state and heme coordination properties of all four human globins. The X-ray crystal structure of tetrameric hemoglobin (Hb) displays the b1 subunit as a ribbon structure, while the entire structure of monomeric myoglobin (Mb) is shown as a ribbon, positioned relative to Hb b1. The coordinated heme is highlighted in cyan in both structures. <bold>b</bold> Structural properties of five-coordinate heme-bound Fe(II) (Hb and Mb) binding to oxygen. In the deoxy conformation, Fe(II) sits out of plane from the tetradentate heme. Oxygen binding facilitates shift to stable, tetrahedral geometry in oxyhemoglobin. <bold>c</bold> oxygen binding properties of Hb and Mb. Hb exhibits cooperative binding as the oligomers transition from T-state to R-state after one oxygen binds. Mb exhibits hyperbolic binding because it functions as a monomer. <bold>d</bold> Redox properties of oxygen coordination to heme. <bold>e</bold> Strategies adopted to modify or delivery globins for use as an artificial blood supply. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e643" position="float" orientation="portrait" xlink:href="41467_2024_48719_Fig4_HTML.jpg"/></fig></p><p id="Par19">The reversibility of oxygen binding makes hemoglobin an attractive target for biomedical oxygen delivery. Hemoglobin-based oxygen carriers (HBOCs) have been investigated as blood substitutes in order to reduce dependence on allogeneic RBC transfusions<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>. This was initiated by Amberson et al. in 1934, who isolated hemoglobin from hemolysed beef RBCs to create a Ringer-Locke solution that, when provided as a blood substitute into cats, allowed survival for up to 36&#8201;h<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Though promising, many initial HBOCs suffered from toxicity and side effects. Clinical studies of cell-free HBOCs have caused renal toxicity in patients<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, due to the formation of hemoglobin <italic toggle="yes">&#945;</italic><italic toggle="yes">&#946;</italic> heterodimers that are cleared through renal catabolism<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>.</p><p id="Par20">The first HBOC approved for clinical trial by the FDA was HemAssist, which utilized a fumarate crosslinker to crosslink the two <italic toggle="yes">&#945;</italic>-subsunits of hemoglobin purified from human blood banks. It was ultimately discontinued after a Phase III trial due to an increased risk of pancreatitis and myocardial infarction<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Other potential issues include nitric oxide (NO)-scavenging and met-hemoglobin formation, causing hypertension and vasoconstriction. Recent advances in HBOCs include its use to promote wound healing, particularly for diabetic ulcers. For instance, &#8217;Granulox&#8217; is a topical spray consisting of purified porcine hemoglobin that has clinically demonstrated improved healing in poorly oxygenated wounds<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Globin-modified biomaterials have also been tested for their neuroprotective/regenerative potential in preclinical models (namely traumatic brain injury and stroke). These have included regional reperfusion using HemoAct (a core-shell structured hemoglobin-albumin cluster)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> and delivery of HBOCs, including modified nanoparticles thereof containing the catalase enzyme to provide additive benefits<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and polynitroxylated polyethylene glycol (PEG)-ylated hemoglobin. However, in the latter, as with previous studies of HBOCs, deployment in larger species (<italic toggle="yes">pig</italic>) resulted in hypertension and cardiac arrest, questioning the future utility of this approach or need for further development<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p><p id="Par21">To alleviate these limitations, current work on HBOCs focuses on (i) reducing the toxicity of free hemoglobin, (ii) limiting oxidation to met-hemoglobin without comprising oxygen binding and (iii) exploring HBOC modifications such as polymerization, crosslinking and genetic engineering to increase hemoglobin half-life while in intravascular circulation<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. For example, Jansman et al., have developed a nanoparticle solution that encapsulates hemoglobin in poly(lactide-co-glycolide) (PLGA) decorated with cerium oxide, which acts as an enzyme mimic to scavenge ROS. To improve the circulating half-life of the nanoparticle and reduce sequestering into the liver or spleen, the surface was further functionalised with components derived from RBC membranes<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. In vitro studies of the nanoparticles demonstrated biocompatibility, ROS scavenging capability, preserved protein function and limited endothelial cell uptake. However, further investigation using appropriate in vivo models is required to elucidate whether such materials will avoid the clinical challenges of earlier HBOCs.</p><p id="Par22">A secondary function of hemoglobin is to facilitate the transport of waste gas from tissue to the lungs. This property of hemoglobin remains somewhat overlooked in the context of HBOCs, and could present an opportunity for further investigation, especially when considering the need for metabolic waste sequestration, removal, and the effect on the acid-base balance in engineered tissues<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. One area where carbon dioxide (CO<sub>2</sub>, waste/ by-product of metabolism) content has been investigated is in applications such as organ preservation via machine perfusion<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and severe hemorrhagic shock models<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Here, glutaraldehyde polymerized HBOCs were utilized as blood substitutes. In the latter example, Chang&#8217;s group<sup><xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref></sup>, crosslinked the polyhemoglobin (polyHb) with antioxidant enzymes SOD and CAT, and carbonic anhydrase (CA). CA catalyzes the hydration of CO<sub>2</sub>, to boost efficiency of CO<sub>2</sub> transport away from tissues. The polyHb-SOD-CAT-CA complex demonstrated lower intracellular pCO<sub>2</sub> (68.6&#8201;&#177;&#8201;3&#8201;mmHg) compared with lactated Ringer&#8217;s solution (98&#8201;&#177;&#8201;4.5 mmHg) and polyHb (90.1&#8201;&#177;&#8201;4.0&#8201;mmHg)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Such work illustrates that despite the potential of HBOCs to concurrently transport oxygen and waste CO<sub>2</sub>, hemoglobin on its own may not be sufficient to maintain acid-base balance (hemoglobin transport accounts for only 23% of sequestered CO<sub>2</sub> in the body, with the 70% of the remaining catalyzed by CA<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>). However, caution should be taken when chemically modifying and crosslinking enzymes, as such modifications can result in a decrease in functional activity.</p></sec><sec id="Sec8"><title>Myoglobin and myoglobin-engineered molecules</title><p id="Par23">Myoglobin is another important hemoprotein that is endogenous to most vertebrates and reversibly binds oxygen. Myoglobin shares the eight alpha-helical structural motif of hemoglobin subunits but is distinct in that it is a monomer functioning as an oxygen reservoir. It has higher oxygen affinity than hemoglobin, with P<sub>5</sub><sub>0</sub> (pO<sub>2</sub> at half oxygen saturation) values of approximately 2&#8211;3 mmHg<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> and 27 mmHg<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, respectively. Expressed in cardiac and skeletal muscle, myoglobin binds oxygen transferred from arterial hemoglobin because of this affinity difference. Oxygen release from myoglobin to the mitochondria of myocytes will occur when demand is high, like during aerobic exercise<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>.</p><p id="Par24">Myoglobin can be exploited for oxygen storage to mediate hypoxic conditions in bioengineered tissues, usually through complexation or immobilization. Some examples of myoglobin being applied in this context include studies of its covalent immobilization and inclusion within sol/gel films<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. Engineered myoglobin was also encapsulated within peptide-based hydrogels to deliver oxygen to transplanted neural progenitor cells<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. After 28 days post-transplantation in mice, there was significant increase in graft volume and innervation for groups horse and sperm whale myoglobin. However, the high oxygen-affinity (P<sub>5</sub><sub>0</sub> = 0.007 mmHg) sperm whale myoglobin mutant demonstrated the greatest impact, suggesting that there is a delicate balance between preventing hypoxia and oversupplying oxygen (e.g., for arterial PO<sub>2</sub> &gt;120 mmHg)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Armstrong et al., had engineered a myoglobin-polymer-surfactant complex designed to bind to cell membranes and directly deliver oxygen when cellular levels were critically low. When applied to human MSCs in an in vitro model of cartilage, it was found that the technology not only alleviated hypoxia, but also improved the overall distribution and composition of the tissue<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>.</p><p id="Par25">An important consideration to make when engineering structural and functional changes to myoglobin is the relationship between stability and activity. It is well known that myoglobin will auto-oxidize to inactive metmyoglobin, which can subsequently react with hydrogen peroxide to form ferryl heme. This highly reactive species can initiate lipid peroxidation<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Future work would benefit from exploring methods to reduce myoglobin auto-oxidation and conducting longer in vivo studies to determine protein retention and stability.</p></sec><sec id="Sec9"><title>Neuroglobin</title><p id="Par26">Within the last two decades, a newly discovered globin has been isolated from mouse and human neuronal tissue<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. With a similar oxygen affinity to myoglobin (<italic toggle="yes">P</italic><sub>5</sub><sub>0</sub>&#8201;=&#8201;1&#8211;10&#8201;mmHg), in vivo experiments indicate its role in protecting the brain and nervous system from hypoxia and oxidative stress<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>.</p><p id="Par27">Overexpression of neuroglobin increases neuron survival and viability after oxidative stress<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. Studies where neuroglobin-expressing adeno-associated viral vectors were administered into the cortex of a rat stroke model showed reduced infarct size (49&#8722;52% reduction compared with control groups) and improved functional outcomes<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. Furthermore, when neuroglobin was overexpressed in mice hearts, ischemic injury was significantly reduced (reduction of&#8201;~25&#8722;30%). These findings suggest that neuroglobin possesses an enhanced ability to protect cells against oxidative stress in comparison to myoglobin<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Further investigation into neuroglobin and other under-studied hemoproteins, such as cytoglobin, could therefore be beneficial to the field of tissue engineering.</p></sec><sec id="Sec10"><title>Enzyme systems modulating oxygen delivery</title><p id="Par28">Physiological reactions involving oxygen or electron transfer tend to produce ROS as by-products (see Box&#160;<xref rid="Sec11" ref-type="sec">1</xref>).</p><p id="Par29">Clearance of ROS, when they form in the ETC, is managed by enzymes such as SOD and CAT. CAT is capable of both sequestering H<sub>2</sub>O<sub>2</sub> and generating oxygen, both of which are advantageous in the context of some oxygenated biomaterials. For example, hydrophobic oxygen generating microparticles (HOGMPs), composed of calcium peroxide-laden poly(caprolactone) (PCL) microparticles, can generate toxic levels of H<sub>2</sub>O<sub>2</sub> as a by-product. By co-entrapment of the HOGMP with CAT in a hydrogel, H<sub>2</sub>O<sub>2</sub> levels are reduced under hypoxic conditions, improving the viability and metabolic activity of cells cultured within the hydrogel for up to seven days<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Clearly, coadministration of oxygen- or redox-functional enzymes can alleviate challenges caused by oxygen delivery systems in vivo, in addition to facilitating delivery themselves.</p><p id="Par30">Exogenous enzymes from bacteria, archaea and plants have also been explored as a means to deliver oxygen to hypoxic tissues. For example, a prokaryotic chlorite O<sub>2</sub>-lyase enzyme, which catalyzes the conversion of chlorite (ClO<sub>2</sub>-) into oxygen, can be heterologously expressed at high levels in human cells. Coexpression of a chlorite transporter to facilitate chlorite import was shown to initiate molecular oxygen production inside cells in response to extracellular chlorite. For example, when 5 million chlorite O<sub>2</sub>-lyase expressing HeLa cells were subjected to a pulse of 1 mM sodium chlorite, 0.359&#8201;&#177;&#8201;0.01&#8201;&#956;mol of oxygen was generated over a period of 30s<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. This coexpression technology, SNORCL, is an example of how the functional diversity of oxygen-related enzymes in all kingdoms of life can be taken advantage of for oxygen delivery if appropriate candidates are identified.</p></sec><sec id="Sec11"><boxed-text position="float" orientation="portrait"><label>Box 1 Oxygen and ROS in cell signaling and pathology</label><p id="Par31">The primary cellular organelle that utilizes oxygen is the mitochondrion during oxidative phosphorylation, the ETC and ATP synthesis (see Fig.&#160;<xref rid="Fig3" ref-type="fig">3)</xref>. Consequently, it is considered a major producer of ROS within the cell. It is hypothesized that singular electrons that leak from Complex I and III are available to then reduce molecular oxygen to superoxide (O<sub>2</sub>&#8226;-). Notably, nicotinamide adenine dinucleotide phosphate (NADPH) oxidases are also a significant source of cellular O<sub>2</sub>&#8226;-<sup><xref ref-type="bibr" rid="CR126">126</xref></sup>. There are a number of antioxidant systems that sequester ROS, such as by superoxide dismutase (SOD), which catalyzes the dismutation of O<sub>2</sub>&#8226;- into a more stable product - hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). H<sub>2</sub>O<sub>2</sub> is then reduced to water by catalase (CAT) or glutathione peroxidase (GPX). H<sub>2</sub>O<sub>2</sub> is an important signal transduction molecule involved in the activation and regulation of a number of different metabolic pathways. This includes regulation of HIFs, cellular proliferation and differentiation pathways such as the mitogen-activated protein kinase (MAPK) pathway, cellular growth through the phosphatidylinositol 3 kinase (PI3K) pathway and cellular apoptosis through the nuclear factor-<italic toggle="yes">&#954;</italic>B (NF-<italic toggle="yes">&#954;</italic>B) pathway. Furthermore, an increase in ROS production as a result of NADPH oxidase activation upon infection has been linked to the transcription of proinflammatory cytokines<sup><xref ref-type="bibr" rid="CR127">127</xref></sup>.</p><p id="Par32">Antioxidant safeguards are overwhelmed when there is mitochondrial damage or increased activation of NADPH oxidase, such as in the case of ischemic/ reperfusion injury. The accumulation of O<sub>2</sub>&#8226;- and/or H<sub>2</sub>O<sub>2</sub> can lead to the formation of highly reactive hydroxyl free radicals (HO&#8226;-) via a Haber-Weiss reaction, which in turn cause severe oxidative stress through lipid, protein and DNA oxidation. It is also well-established that hypoxia induces oxidative stress<sup><xref ref-type="bibr" rid="CR128">128</xref></sup>. The precise mechanisms underlying hypoxia-induced ROS production remains unknown. However, one hypothesis is that a higher ratio of NADH/NAD+ under these conditions in turn increases electron transport through protein complex I, thus promoting O<sub>2</sub>&#8226;- production<sup><xref ref-type="bibr" rid="CR129">129</xref></sup>. Additionally, unstable intermediates (e.g. ubisemiquinone) of the Q-cycle are also believed to contribute to O<sub>2</sub>&#8226;- production under non-phosphorylating conditions<sup><xref ref-type="bibr" rid="CR130">130</xref></sup>. This highlights the need to maintain the oxygen homeostasis within engineered tissues, as there is evidence that both hyperoxic and hypoxic environments can lead to pathologic ROS generation.</p><p id="Par33">ROS modulation has also been explored in the context of anti-cancer therapies. For instance, increasing oxygen supply in tumors&#8217; necrotic core can improve radiation and photo-dynamic therapies. This relies on the conversion of newly available oxygen into ROS leading to cell death<sup><xref ref-type="bibr" rid="CR131">131</xref>,<xref ref-type="bibr" rid="CR132">132</xref></sup>.</p></boxed-text></sec><sec id="Sec12"><title>Other biomolecules</title><p id="Par34">Serum albumins are transport proteins found in plasma that can bind diverse hydrophobic ligands such as water, hormones, fatty acids, cations, bilirubin and thyroxine. Notably, albumin has high affinity for heme, and can act as a hemoprotein for oxygen transportation<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. A limitation of heme-bound albumin is that the protein lacks the distal histidine of the globins, leading to rapid oxidation of the heme complex. To alleviate this, site-directed mutagenesis of the binding pocket to introduce a proximal histidine, as in the globin superfamily, can generate a heme-specific cleft and facilitate reversible oxygen binding, albeit with lower oxygen binding affinities (P<sub>5</sub><sub>0</sub> = 18 - 134 mmHg) compared to hemoglobin and myoglobin<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Given the functional and structural diversity of oxygen-binding hemoproteins, there is clear potential to use evolved, engineered or de novo proteins to generate biomaterials capable of appropriate oxygen delivery depending on the application.</p><p id="Par35">A recent approach to introducing oxygen into tissue-engineered constructs involves leveraging the properties of Synechococcus elongatus, a photoautotrophic cyanobacterium that can transform carbon dioxide into oxygen through photosynthesis, across a broad excitation spectrum (440&#8211;680 nm). S. elongatus has facilitated oxygenation in cardiac tissues during episodes of ischemic stroke<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. The application of S. elongatus has been extended to the domain of bioprinting, providing oxygenation for cell constructs under hypoxic conditions<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>.</p></sec></sec><sec id="Sec13"><title>Biomaterials and devices for oxygen generation &amp; perfusion</title><p id="Par36">In the context of oxygen for tissue engineering, the lack of a robust, native vasculature in scaffolds or engineered grafts has both ramifications for both oxygen transport, and waste removal. Engineered approaches toward reproducing this oxygenating architecture have been attempted. For example, fabrication techniques are employed to mimic vasculature and introduce artificial channels (refer to Box&#160;<xref rid="Sec14" ref-type="sec">2</xref>). Notably, in the context of in vitro applications (where most preliminary data is gathered), the media is periodically replaced, thereby removing waste metabolites. Therefore, in these models the focus has been on controlling the delivery of oxygen via chemical or mechanical means. Examples of this include the use of chemical additives such as peroxides and perfusing bioreactors; however, more recently the discussion extends to the generation of artificial blood through oxygen-carrying perflourocarbons. Recent advances on these strategies and release kinetics are discussed below (refer also to Box&#160;<xref rid="Sec15" ref-type="sec">3</xref>).</p><sec id="Sec14"><boxed-text position="float" orientation="portrait"><label>Box 2 Vascularisation and engineered oxygenating architecture</label><p id="Par37">Vascularization can be achieved by stimulating angiogenesis and activating the host microvasculature. Several engineering approaches, including (i) the modification of the chemical composition, architecture, and porosity of constructs; (ii) the addition of angiogenic growth factors such as VEGF, and (iii) cell seeding with endothelial cell (EC) progenitors, have been employed to promote the ingrowth of new blood vessels<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. However, this process is slow (8 weeks-8 months)<sup><xref ref-type="bibr" rid="CR133">133</xref>,<xref ref-type="bibr" rid="CR134">134</xref></sup>.</p><p id="Par38">Alternatively, template channels or structures can be fabricated within engineered tissue scaffolds to direct the distribution of EC progenitors towards forming organized, interconnected tubular vascular networks, thus enhancing the integration of grafted ECs (and by extension, other transplanted cells) with the host<sup><xref ref-type="bibr" rid="CR135">135</xref>&#8211;<xref ref-type="bibr" rid="CR137">137</xref></sup>. Without such structures, encapsulating ECs leads to an unstable or unconnected tubular network and irregular vessel architecture. This can increase the susceptibility to early thrombosis<sup><xref ref-type="bibr" rid="CR138">138</xref></sup> and cause delays between implantation and perfusion<sup><xref ref-type="bibr" rid="CR139">139</xref></sup>.</p><p id="Par39">Techniques for building perfusable template channels include micromolding, laser degradation, 3D printing, and coaxial microfluidic spinning<sup><xref ref-type="bibr" rid="CR140">140</xref></sup>. For example, an aligned &#8220;cord" consisting of ECs and collagen fabricated by microtissue molding can form new capillaries along its length (1&#8201;cm). When studied in the context of hepatocyte transplantation, the survival of hepatocytes and hepatic function were significantly enhanced<sup><xref ref-type="bibr" rid="CR141">141</xref></sup>. Despite the ease of micromolding, this technology remains limited by the design constraints on the planar substrate<sup><xref ref-type="bibr" rid="CR142">142</xref></sup>. 3D bioprinting can also be implemented to generate heterogeneous tissue with multiple patterned cells, materials, and vascular channels<sup><xref ref-type="bibr" rid="CR142">142</xref></sup>. However, bioinks have limitations, such as possible shear damage to cells during extrusion<sup><xref ref-type="bibr" rid="CR143">143</xref></sup>. Coaxial microfluidic spinning has created an exciting avenue for biomaterials. In this technique, hollow microfibers are formed by the flowing fluids in microfluidic devices. Yu et al. demonstrated how ECs can be encapsulated into the microfibres, driving an annular distribution of the cells along the direction of the microfibers<sup><xref ref-type="bibr" rid="CR144">144</xref></sup>, thus successfully constructing vessels<sup><xref ref-type="bibr" rid="CR145">145</xref></sup>. However, these materials are not robust and require delicate handling<sup><xref ref-type="bibr" rid="CR144">144</xref></sup>.</p><p id="Par40">Providing a prevascularised environment for transplanted cells has other advantages in addition to oxygen delivery, as it also enables waste exchange. As such, materials utilized to preform vasculature should be permeable to water-soluble gases, metabolites and molecules<sup><xref ref-type="bibr" rid="CR146">146</xref></sup>.</p><p id="Par41">Current challenges of preformed artificial vasculature include the demand for customized and expensive equipment or materials, such as laser-ablation microscopes, sterile environments, 3D printers, or unique bioinks<sup><xref ref-type="bibr" rid="CR147">147</xref></sup>. This highlights the necessity for the development of simpler, less expensive approaches to improve scalability and accessibility. Importantly, preformed vasculatures require rapidly developing interconnections to the host tissue post-implantation. Notably, on implantation of the prevascularised materials in vivo, the host models and anatomic implant locations need to be taken into consideration, as any discrepancies can illicit an inflammatory response<sup><xref ref-type="bibr" rid="CR139">139</xref></sup>.</p></boxed-text></sec><sec id="Sec15"><boxed-text position="float" orientation="portrait"><label>Box 3 Mechanisms of oxygen delivery from secondary materials</label><p id="Par42">The encapsulation of biomolecules, peroxides, perflourocarbons and nanobubbles into second materials that limit their release kinetics (i.e. secondary encapsulation) is common method to prolong oxygen delivery. The oxygen release is thus influenced by i) the primary material or biomolecule and ii) the secondary matrix in which the primary material or biomolecule is encapsulated. As such, the release is an interplay between the material characteristics, the biological demands (and events such as enzymatic degradation), and the encapsulating method<sup><xref ref-type="bibr" rid="CR148">148</xref></sup>. When a matrix is implanted or injected at time <italic toggle="yes">t</italic>&#8201;=&#8201;0 where the polymer relaxation time <italic toggle="yes">t</italic><sub><italic toggle="yes">r</italic></sub> and the characteristic diffusion time <italic toggle="yes">T</italic><sub><italic toggle="yes">d</italic></sub> satisfies (<italic toggle="yes">t</italic><sub><italic toggle="yes">r</italic></sub>)&#8201;&gt;&gt;&#8201;<italic toggle="yes">T</italic><sub><italic toggle="yes">d</italic></sub>, diffusion will be governed typically by Fickian diffusion mechanisms described by Fick&#8217;s second law<sup><xref ref-type="bibr" rid="CR149">149</xref></sup>. However, other cases of mass transport have also been described (such as non-Fickian) and various mathematical models have been proposed describing release profiles (or fractional amounts released), material geometries (such as particles and slabs), or physicochemical characteristics (e.g., swelling and degradation)<sup><xref ref-type="bibr" rid="CR150">150</xref></sup>.</p><p id="Par43">Hydrogels for tissue engineering and regenerative medicine often present a release characterized by a rapid burst at early time points (<italic toggle="yes">t</italic>&#8201;&lt;&#8201;12<italic toggle="yes">h</italic>) followed by a slow release, e.g.(24<italic toggle="yes">h</italic>&#8201;&lt;&#8201;<italic toggle="yes">t</italic>&#8201;&lt;&#8201;30<italic toggle="yes">d</italic><italic toggle="yes">a</italic><italic toggle="yes">y</italic><italic toggle="yes">s</italic>), or cargo depletion. The rate of release from these hydrogels -in the absence of binding mechanisms- strongly depends on the physical characteristics between the cargo (e.g., molecular weight and charge) and the material (e.g., the mesh size (<italic toggle="yes">&#950;</italic>)<sup><xref ref-type="bibr" rid="CR151">151</xref>,<xref ref-type="bibr" rid="CR152">152</xref></sup>. In contrast, high-swelling hydrogel matrices or erodible polymers associate the release of the cargo with combined diffusion and surface/ bulk degradation mechanisms. An exemption to this is when the oxygen-carrying molecule is part of the matrix itself, as exemplified by the work of Park et al., where a thiolated gelatin was crosslinked via calcium peroxide-mediated oxidative reaction<sup><xref ref-type="bibr" rid="CR153">153</xref></sup>. Similarly, Ding et al., fabricated an oxygen generating and ROS-scavenging injectable hydrogel based on the reaction between synthetic ROS-cleavable hyperbranched polymers and methacrylate hyaluronic acid<sup><xref ref-type="bibr" rid="CR154">154</xref></sup>.</p><p id="Par44">The complexity of the release kinetics extends to the use of multi-encapsulating materials (e.g., microspheres containing peroxides encapsulated in scaffolds). In theory, the release kinetics of a system designed to constantly release oxygen can be expected to follow a zero-order kinetics (described by <italic toggle="yes">C</italic>&#8201;=&#8201;<italic toggle="yes">C</italic><sub>0</sub>&#8201;+&#8201;<italic toggle="yes">k</italic><sub>0</sub><italic toggle="yes">t</italic> where <italic toggle="yes">C</italic> is the amount of oxygen released at time <italic toggle="yes">t</italic>, and <italic toggle="yes">C</italic><sub>0</sub> is the initial amount of drug in the solution and <italic toggle="yes">K</italic><sub>0</sub> the zero-order constant). However, this material design might not be parallel to the oxygen demands in biological systems that constantly fluctuate its therapeutic window.</p></boxed-text></sec><sec id="Sec16"><title>Peroxides</title><p id="Par45">Many non-biological approaches for in situ oxygen delivery have been explored. Perhaps the most prominent example is the integration of inorganic peroxides. Both soluble and solid peroxides are effective at oxygen release<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. They work by directly releasing hydrogen peroxide, which chemically decomposes to form water and molecular oxygen (following the chemical decomposition reaction, 2<italic toggle="yes">H</italic><sub>2</sub><italic toggle="yes">O</italic><sub>2</sub>&#8201;&#8594;&#8201;2<italic toggle="yes">H</italic><sub>2</sub><italic toggle="yes">O</italic>&#8201;+&#8201;<italic toggle="yes">O</italic><sub>2</sub>). Their oxygen release rate varies depending on the purity and solubility of the peroxides (e.g., solubility <italic toggle="yes">C</italic><italic toggle="yes">a</italic><italic toggle="yes">O</italic><sub>2</sub>: 1.65g/L vs <italic toggle="yes">M</italic><italic toggle="yes">g</italic><italic toggle="yes">O</italic><sub>2</sub>: 0.86g/L), presence of antioxidants (e.g., enzyme systems), and parameters such as temperature and pH. However, under physiological conditions (pH 5-7, 37&#8201;&#176;C) rapid decomposition upon liquid exposure (&#8804;48h), termed burst oxygen generation, can be expected<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. This is problematic for regenerative approaches that require sustained oxygen release (days-months).</p><p id="Par46">Mammalian cells can decompose 2<italic toggle="yes">H</italic><sub>2</sub><italic toggle="yes">O</italic><sub>2</sub> at low concentrations via <italic toggle="yes">2-cys peroxiredoxin</italic> scavenger. However, excess (&gt;10 nM) can lead to intracellular perturbation, causing oxidative damage and triggering apoptosis<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. Consequences include tissue damage and gas emboli (e.g., arterial emboli). In addition, tissue detriment can originate from the highly exothermic reaction (standard enthalpy of &#8722;98.2&#8201;kJ/mol) itself&#8201;<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR81">81</xref></sup>. As such, challenges for integrating peroxides into tissue engineering solutions include: (i) optimizing exposure time and concentration while balancing redox reactions; (ii) tissue selectivity; and (iii) decreasing toxicity.</p><p id="Par47">To mitigate the adverse effects of burst oxygen generation, a strategic approach is to reduce peroxide exposure to water by encapsulating them within polymeric structures<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. Synthetic polymers, such as PCL, have been explored for this purpose, achieving dissolved oxygen concentrations ranging from 5% to 29% (0.12&#8211;0.71 mmHg) with increasing peroxide loading<sup><xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup>. Another example is the use of in situ oxygen generation, such as by Coronel et al., where, by using calcium peroxide encapsulated in polydimethylsiloxane tablets, oxygen was raised from 0.1 mmHg to 214 mmHg, resulting in reduced anaerobic glycolysis and stimulating insulin release in pancreatic islets. From these examples, it is evident that the release rate also depends on the peroxide (e.g., molecular weight <italic toggle="yes">C</italic><italic toggle="yes">a</italic><italic toggle="yes">C</italic><italic toggle="yes">O</italic><sub>3</sub> MW= 100 g/mol), the encapsulating material properties and the morphology of the delivery vehicle (e.g., nanosized particles vs bulk hydrogels)<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. Recent research has devised parameters for oxygen release from encapsulating materials, of which the interested reader can find further discussion in Box&#160;<xref rid="Sec15" ref-type="sec">3</xref>.</p><p id="Par48">An additional reported advantage of controlling oxygen release is the indirect reduction of ROS and free radicals. As discussed in Section 3.4., this can be enhanced by the supplementation of antioxidants such as CAT enzymes<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>. This has been exploited to create bioinks for 3D-printed constructs, improving cell viability under severe hypoxia (1&#8722;5%)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. The use of peroxides incorporated in bio-inks has the goal of improving spatial distribution of peroxides while satisfying the need for oxygen in large 3D printed structured and further into large tissue repair<sup><xref ref-type="bibr" rid="CR87">87</xref>,<xref ref-type="bibr" rid="CR88">88</xref></sup>. The introduction of oxygenating architecture within bioinks can also serve as a structural support for maturation. With these strategies to control the spatio-temporal release of oxygen through physical encapsulation, gradient-controlled oxygen release patterns could be expected soon.</p></sec><sec id="Sec17"><title>Perfluorocarbons</title><p id="Par49">Perfluorocarbons (PFCs) differ structurally from conventional alkyl chains. The abbreviation &#8217;PFC&#8217; often refers to perflourinated chemicals. Herein, PFCs denote only perflourocarbons. In comparison to hydrocarbon chain (H-chains), F-chains adopt a helical arrangement (versus the planar configuration of H-Chains) and a more rigid structure (cross section of ca. 30 &#8491;2). In PFCs (C<sub><italic toggle="yes">a</italic></sub>F<sub><italic toggle="yes">b</italic></sub>) the flourine atoms surrounding the carbon backbone contribute to their hydrophobic nature, enabling them to accommodate gases, including oxygen. The solubility of oxygen in PFCs is up to one thousand times the solubility of oxygen in water, with a molecular ratio of dissolved oxygen 1<sub><italic toggle="yes">O</italic>2</sub>:&#8201;200 in water compared to 5<sub><italic toggle="yes">O</italic>2</sub>:&#8201;1 in PFCs, such as perfluorodecalin<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>.</p><p id="Par50">The use of PFCs to provide oxygen in aqueous solutions was first proposed in 1966, and later as blood substitutes<sup><xref ref-type="bibr" rid="CR90">90</xref></sup>. Unlike globins, PFCS oxygen release kinetics vary linearly according to pO<sub>2</sub> (following Henry&#8217;s law), and for blood applications, its oxygen-carrying capacity is often compared against hemoglobin. For instance, the oxygen-delivering capacity of a 1-g PFC/kg body weight dose is estimated to be around 1.5 g hemoglobin for commercial blood-substitute, Oxygent<sup><xref ref-type="bibr" rid="CR91">91</xref></sup>. After decades of investigation, clinical use of PFCs as blood substitutes and as oxygen carriers for tissue engineering still faces challenges, including: (i) fabricating an optimized, stable formulation; (ii) overcoming interference with clinical oxygen measurements; and (iii) a reliable large production process.</p><p id="Par51">Optimizing PFCs formulations to improve their limited miscibility has been tested by using nanoemulsions as parental formulations. Common emulsion parameters, such as droplet size (10-1000 nm), fabrication method, and surfactant choice, influence their stability and shelf-life<sup><xref ref-type="bibr" rid="CR92">92</xref>,<xref ref-type="bibr" rid="CR93">93</xref></sup> (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>). Commercial oxygen delivery systems based on PFCs have included emulsions loaded with 11&#8722;40% PFCs. Efforts to optimize carriers for PFCs continue, with recent research focusing on fabricating deformable core-shell particles<sup><xref ref-type="bibr" rid="CR94">94</xref></sup>, using natural molecule-based carriers (such as albumin)<sup><xref ref-type="bibr" rid="CR95">95</xref></sup>, sequence-controlled delivery<sup><xref ref-type="bibr" rid="CR96">96</xref></sup> and doubly encapsulated integrated into lipid particle-hydrogel scaffolds<sup><xref ref-type="bibr" rid="CR97">97</xref></sup>.<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><title>Controlled delivery strategies, oxygen release mechanisms and challenges in the field.</title><p><bold>a</bold> Oxygen-controlled release strategies include physical entrapment in emulsions of monodiperse size (e.g., microfluidic-generated) or polydispersed (particle dependent on velocity and shear of the system) generating particles such as micelles or multi-layered particles. Other strategies include scaffold encapsulation and stimuli-dependent release. <bold>b</bold> Core release mechanisms for biomaterials and devices able to generate oxygen. <bold>c</bold> Remaining challenges in the field of oxygen tissue engineering. Figure created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1385" position="float" orientation="portrait" xlink:href="41467_2024_48719_Fig5_HTML.jpg"/></fig></p><p id="Par52">Few toxic effects have been linked to PFCs, and often the effects are attributed to co-factor deposition (e.g., hepatic deposition &gt;65 days) and surfactant-related side effects. Despite of this, industrial PFCs gases derived mainly from electronic manufacturing, are considered potent pollutants<sup><xref ref-type="bibr" rid="CR98">98</xref></sup>. In the context of tissue engineering and clinical use, a consideration is the interference of PFCs with pulse oximetry equipment and chemistry analytes<sup><xref ref-type="bibr" rid="CR99">99</xref>,<xref ref-type="bibr" rid="CR100">100</xref></sup> which could be overcome by turbidity correction algorithms as proposed by Toffaletti et al.<sup><xref ref-type="bibr" rid="CR101">101</xref></sup>. In addition, product quality control for PFCs must be closely regulated. Lambert et al., have recently discussed parameters for scaling up the process to use PFCs for oxygen delivery and proposed a quality by-design practice adaptation for PFC nanoemulsion optimization<sup><xref ref-type="bibr" rid="CR102">102</xref></sup>. Broad adoption of these methods could improve PFC translatability.</p></sec><sec id="Sec18"><title>Nanobubbles</title><p id="Par53">Nanobubbles are single bubbles that are inherently unstable and have a theoretical lifespan of&#8201;&lt;1s according to Laplace pressure &#916;<italic toggle="yes">P</italic>&#8201;=&#8201;2(<italic toggle="yes">&#948;</italic>/<italic toggle="yes">r</italic>), where r is the radius of the bubble and <italic toggle="yes">&#948;</italic> is the interfacial pressure<sup><xref ref-type="bibr" rid="CR103">103</xref></sup>. As a result, lowering surface tension can help to maintain their stability by reducing the interfacial pressure (e.g., by PEGylated lipids). Reducing the particle size (10-200 nm) as well as avoiding coalescence (e.g., negative charge increase: &#8722;15 to &#8722;60&#8201;mV) can also improve their oxygenating potential.</p><p id="Par54">Nanoblubbles can be created in biological solutions such as cell culture media via gas-liquid agitation method with oxygen discharge over 48 h (with 31% of initial nanobubbles remaining intact after this time)<sup><xref ref-type="bibr" rid="CR104">104</xref></sup> but their containment via shell entrapping the gas core using lipids, proteins, and polymers can extend their lifespan (12&#8211;100 days)<sup><xref ref-type="bibr" rid="CR105">105</xref>,<xref ref-type="bibr" rid="CR106">106</xref></sup>. When integrated into engineered polymeric scaffolds, nanobubbles gradually discharge oxygen (8 h-8 weeks), shifting hypoxic conditions, and have shown efficiency in maintaining cellular metabolism in vivo (8 weeks)<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>. Integration of nanobubbles needs careful design; methods like sonication create particles of varied sizes (10-500 nm)<sup><xref ref-type="bibr" rid="CR108">108</xref></sup>, making it difficult to anticipate the oxygen release rate. To overcome this, fabrication techniques such as microfluidic-formed nanobubbles have emerged<sup><xref ref-type="bibr" rid="CR109">109</xref>,<xref ref-type="bibr" rid="CR110">110</xref></sup>.</p><p id="Par55">A limitation of encapsulated nanobubbles is that excessive encapsulation can hinder oxygen release, negating their intended purpose. Stimuli-responsive oxygen release is an emerging method to improve this. An emerging approach is to use microbubble-enhanced ultrasound to disrupt physiological barriers, such as the blood-brain barrier (BBB) for brain drug delivery<sup><xref ref-type="bibr" rid="CR111">111</xref></sup> (Fig.&#160;<xref rid="Fig5" ref-type="fig">5)</xref>, which works by disrupting a particle&#8217;s membrane layer via cavitation, thus allowing on-demand oxygen release. For example, Wang et al., used phase transition-triggered low-intensity ultrasound nanobubbles that were filled with hemoglobin and then mixed into gelatine methacrylol (GelMA)<sup><xref ref-type="bibr" rid="CR112">112</xref></sup>. The authors used a blend of GelMA-Hemoglobin nanobubbles to 3D print cardiomyocyte patches and showed increased cell survival against non-hemoglobin and non-ultrasound-stimulated structures. A challenge to overcome with this technique is that, unless there is continuous production of oxygen-carrying nanobubbles, it is a single-time point delivery mechanism. Low-intensity pulsed ultrasound to target sites and integration of biologicals to carry oxygen as a secondary oxygen release source may address this limitation in future investigations.</p></sec><sec id="Sec19"><title>Oxygen perfusing and oxygen-generating devices</title><p id="Par56">Oxygen-perfusing devices, such as bioreactors, function by circulating dissolved oxygen in media around scaffolds and cells, mechanically assisting in waste removal and supplying fresh nutrients and oxygen<sup><xref ref-type="bibr" rid="CR113">113</xref></sup>. Bioreactors have been investigated for their utility in the maturation of large scaffolds, where the center may otherwise experience reduced pO<sub>2</sub><sup><xref ref-type="bibr" rid="CR114">114</xref></sup>. Common bioreactor types used in tissue engineering are rotating wall vessels, spinner flasks, perfusion, and compression systems. The rate of oxygen transfer can be approximated based on the mass transfer coefficient, concentration gradient and geometry of the bioreactors. An important consideration is that in bioreactors the oxygen transfer rate (OTR) often surpasses the oxygen uptake rate (OUR) from the cells. To satisfy an adequate system, the OTR:OUR must be 1:1 or <italic toggle="yes">O</italic><italic toggle="yes">T</italic><italic toggle="yes">R</italic>&#8805;<italic toggle="yes">O</italic><italic toggle="yes">U</italic><italic toggle="yes">R</italic>. However, this condition is challenged by the constant fluctuations in cellular OUR. Advancements in bioreactors have begun to offer real-time monitoring capabilities, integrated sensors for oxygen tension, and customized flow patterns based on advanced mathematical models to closely mimic physiological conditions<sup><xref ref-type="bibr" rid="CR115">115</xref></sup>.</p><p id="Par57">Microfluidic devices, functioning as micro-bioreactors, contribute to circulating media through microchannels mimicking capillary networks. The advent of &#8220;organ-on-a-chip" systems leverages microfluidics to create complex multi-tissue interfaces, allowing for tissue models and drug testing platforms<sup><xref ref-type="bibr" rid="CR116">116</xref></sup>. Besides the complexity of tissues and microfabrication of advanced vasculature, microfluidics for single-cell oxygenation, tailored systems for cell culture oxygen delivery, and cellular oxygen monitoring are emerging developments<sup><xref ref-type="bibr" rid="CR117">117</xref></sup>. Although on a much smaller scale than the large bioreactors, microfluidic devices still rely on an adequate flow rate and shear stress to provide oxygen to cell cultures, with typical flow rates varying from 0.2 to 3&#8201;&#956;l/min and channels widths from 1 to 200&#8201;&#956;m.</p><p id="Par58">Electronic-assisted microfluidics, or electronic integrated systems for oxygen delivery, are finding a new avenue in regenerative medicine. Electrochemical oxygen generators use electrochemical reactions to split water molecules into molecular hydrogen and oxygen, which can be delivered directly to tissue engineering constructs or fabricated as implantable oxygen devices<sup><xref ref-type="bibr" rid="CR118">118</xref>,<xref ref-type="bibr" rid="CR119">119</xref></sup>. Oxygen dosage can be controlled through pulse width modulation of the electrode potential, providing various oxygen ranges (0&#8211;10&#8201;&#956;mol/h)<sup><xref ref-type="bibr" rid="CR120">120</xref></sup>.</p><p id="Par59">Oxygen monitoring and ROS detection devices, specifically designed for tissue engineering and biomedical applications, offer novel insight into oxygen demands<sup><xref ref-type="bibr" rid="CR121">121</xref>,<xref ref-type="bibr" rid="CR122">122</xref></sup>. An interesting trend is dual-function sensing and delivery of oxygen. For example, a recent study showed a platform for locally producing (321.5&#8201;&#956;mol/h) and measuring oxygen (with a range of 312.5&#8211;1625&#8201;&#956;mol/h) in a wound area<sup><xref ref-type="bibr" rid="CR123">123</xref></sup>.</p><p id="Par60">As the field evolves, the need for accurate measuring of oxygen is evident, with few reliable devices and assays designed for tissue engineering and biomedical applications such as micro-probes (size 50&#8201;&#956;m&#8211;1.5&#8201;mm), luminescence optical sensors (0-500 hPa) and oxygen-reacting cellular assays (via nonspecific energy-dependent endocytosis). A limitation of these is that they are designed for in vitro applications, while in vivo non-invasive products able to test scaffold transplantation performance and bioscaffold cellular development are yet to be developed.</p></sec></sec><sec id="Sec20"><title>Concluding remarks and future directions</title><p id="Par61">The intricate machinery of tissue repair is fueled by oxygen; powering cellular functions, lighting signaling pathways, and enabling structural reorganization to achieve optimal healing or regeneration. Promising avenues have emerged in the past few years to redefine our understanding and approach to tissue regeneration mediated by oxygen delivery. Notably, hemoproteins offer well-studied oxygen binding and releasing kinetics. However, they are prone to degradation and only few investigations have created protective environments to combat this. Designing proteins with higher oxygen retention and their inclusion into novel biomaterials can provide tailored oxygen delivery. To overcome a major limitation of oxygen-generating materials, such as ROS production and subsequent oxidative stress, the use of ROS-targeting enzymes might offer circumvention at cellular microenvironment level.</p><p id="Par62">Despite the undeniable translational potential of PFCs and peroxides in medical applications, a breakthrough medical product remains to be launched. Investigations towards optimized formulations using polymeric encapsulations and receptor-binding interactions have been identified as potential facilitators to this end. The continuous research into PCFs underscores the possibility of overcoming translation barriers (such as scalability) by using new industry fabrication frameworks, thus leading to innovative medical products. 3D printing technologies can offer oxygen-containing bio-inks that promise spatio-temporal oxygen delivery into more complex scaffolds than traditional tissue engineering. However, this development must be accompanied by meeting the fluctuating oxygen demands of the cells confined within bio-inks and also be able to sustain such demands in in vivo scenarios. To that end, deeper investigation of the cellular oxygen demands over regenerative processes is needed. Similarly, oxygen-perfusing devices such as bioreactors and microfluidics have shown the need for adapting miniaturized and precise real-time monitoring capabilities. Future research should aim to improve the precision measurement of oxygen levels and rapid adjustment of oxygen transfer rates to closely match cellular oxygen uptake. Furthermore, the oxygen and oxygen pressure monitoring set-up should move from bulky in vitro systems to accurate, lightweight and minimally invasive in vivo monitoring (e.g. in situ scaffold oxygen-releasing monitoring).</p><p id="Par63">Future research is expected to investigate the fabrication of dynamic materials or devices that can adapt oxygen release in response to their environment and cellular needs. With the regenerative medicine and tissue engineering field continuously pushing boundaries, numerous innovative approaches are on the horizon, holding promise for a golden era of tissue engineering via oxygen delivery systems.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the the Australian Research Council Future Fellowship project FT230100220 (D.N.) and St. Vincent&#8217;s Hospital Melbourne Research Endowment Fund project 94519 (L.C.A.).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Formulation of the concept and structure: L.M.C.A. and D.R.N.; main writing and editing of the manuscript: E.Z. and L.M.C.A.; figure generation and editing: L.M.C.A., E.Z., O.S., and C.O.; subsection writing, manuscript reviewing and editing: Y.W., C.J., O.S., S.D., C.O., B.F., S.E.M., R.W., C.P., and D.R.N.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par64"><italic toggle="yes">Nature Communications</italic> thanks Nic Leipzig, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.</p></sec></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par65">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitrousis</surname><given-names>N</given-names></name><name name-style="western"><surname>Fokina</surname><given-names>A</given-names></name><name name-style="western"><surname>Shoichet</surname><given-names>MS</given-names></name></person-group><article-title>Biomaterials for cell transplantation</article-title><source>Nat. Rev. Mater.</source><year>2018</year><volume>3</volume><fpage>441</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/s41578-018-0057-0</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Croll</surname><given-names>TI</given-names></name><etal/></person-group><article-title>Modelling oxygen diffusion and cell growth in a porous, vascularising scaffold for soft tissue engineering applications</article-title><source>Chem. Eng. Sci.</source><year>2005</year><volume>60</volume><fpage>4924</fpage><lpage>4934</lpage><pub-id pub-id-type="doi">10.1016/j.ces.2005.03.051</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kellner</surname><given-names>K</given-names></name><etal/></person-group><article-title>Determination of oxygen gradients in engineered tissue using a fluorescent sensor</article-title><source>Biotechnol. Bioeng.</source><year>2002</year><volume>80</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1002/bit.10352</pub-id><pub-id pub-id-type="pmid">12209788</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini</surname><given-names>M</given-names></name><name name-style="western"><surname>Brown</surname><given-names>J</given-names></name><name name-style="western"><surname>Shafiee</surname><given-names>A</given-names></name></person-group><article-title>Strategies to induce blood vessel ingrowth into skin grafts and tissue-engineered substitutes</article-title><source>Tissue Eng. Part C Methods</source><year>2022</year><volume>28</volume><fpage>113</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1089/ten.tec.2021.0213</pub-id><pub-id pub-id-type="pmid">35172639</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Biomimetic porous hydrogel scaffolds enabled vascular ingrowth and osteogenic differentiation for vascularized tissue-engineered bone regeneration</article-title><source>Appl. Mater. Today</source><year>2022</year><volume>27</volume><fpage>101478</fpage><pub-id pub-id-type="doi">10.1016/j.apmt.2022.101478</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Potente</surname><given-names>M</given-names></name><name name-style="western"><surname>Gerhardt</surname><given-names>H</given-names></name><name name-style="western"><surname>Carmeliet</surname><given-names>P</given-names></name></person-group><article-title>Basic and therapeutic aspects of angiogenesis</article-title><source>Cell</source><year>2011</year><volume>146</volume><fpage>873</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.08.039</pub-id><pub-id pub-id-type="pmid">21925313</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>SH</given-names></name><name name-style="western"><surname>Ward</surname><given-names>CL</given-names></name><name name-style="western"><surname>Atala</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>BS</given-names></name></person-group><article-title>Oxygen generating scaffolds for enhancing engineered tissue survival</article-title><source>Biomaterials</source><year>2009</year><volume>30</volume><fpage>757</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2008.09.065</pub-id><pub-id pub-id-type="pmid">19019425</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>K</given-names></name><name name-style="western"><surname>Khattak</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhatia</surname><given-names>S</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>S</given-names></name></person-group><article-title>Hydrogel-perfluorocarbon composite scaffold promotes oxygen transport to immobilized cells</article-title><source>Biotechnol. Prog.</source><year>2008</year><volume>24</volume><fpage>358</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1021/bp070160f</pub-id><pub-id pub-id-type="pmid">18293995</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciray</surname><given-names>HN</given-names></name><name name-style="western"><surname>Aksoy</surname><given-names>T</given-names></name><name name-style="western"><surname>Yaramanci</surname><given-names>K</given-names></name><name name-style="western"><surname>Karayaka</surname><given-names>I</given-names></name><name name-style="western"><surname>Bahceci</surname><given-names>M</given-names></name></person-group><article-title>In vitro culture under physiologic oxygen concentration improves blastocyst yield and quality: a prospective randomized survey on sibling oocytes</article-title><source>Fertil. Steril.</source><year>2009</year><volume>91</volume><fpage>1459</fpage><lpage>1461</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.07.1707</pub-id><pub-id pub-id-type="pmid">18722608</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dumoulin</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Effect of oxygen concentration on human in-vitro fertilization and embryo culture*</article-title><source>Hum. Reprod.</source><year>1999</year><volume>14</volume><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1093/humrep/14.2.465</pub-id><pub-id pub-id-type="pmid">10099995</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanassy</surname><given-names>L</given-names></name><etal/></person-group><article-title>Comparison of 5% and ambient oxygen during days 3-5 of in vitro culture of human embryos</article-title><source>Fertil. Steril.</source><year>2010</year><volume>93</volume><fpage>579</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.02.048</pub-id><pub-id pub-id-type="pmid">19342024</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mantikou</surname><given-names>E</given-names></name><etal/></person-group><article-title>Low oxygen concentrations for embryo culture in assisted reproductive technologies</article-title><source>Hum. Reprod. Update</source><year>2013</year><volume>19</volume><fpage>209</fpage><pub-id pub-id-type="doi">10.1093/humupd/dms055</pub-id><pub-id pub-id-type="pmid">23377864</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>MC</given-names></name><name name-style="western"><surname>Keith</surname><given-names>B</given-names></name></person-group><article-title>The role of oxygen availability in embryonic development and stem cell function</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2008</year><volume>9</volume><fpage>285</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1038/nrm2354</pub-id><pub-id pub-id-type="pmid">18285802</pub-id><pub-id pub-id-type="pmcid">PMC2876333</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanderkooi</surname><given-names>JM</given-names></name><name name-style="western"><surname>Ereci&#324;ska</surname><given-names>M</given-names></name><name name-style="western"><surname>Silver</surname><given-names>IA</given-names></name></person-group><article-title>Oxygen in mammalian tissue: methods of measurement and affinities of various reactions</article-title><source>Am. J. Physiol.</source><year>1991</year><volume>260</volume><fpage>C1131</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.1991.260.6.C1131</pub-id><pub-id pub-id-type="pmid">2058649</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz-Prado</surname><given-names>E</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>JF</given-names></name><name name-style="western"><surname>Vasconez</surname><given-names>J</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>D</given-names></name><name name-style="western"><surname>Viscor</surname><given-names>G</given-names></name></person-group><article-title>Partial pressure of oxygen in the human body: a general review</article-title><source>Am. J. Blood Res.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">30899601</pub-id><pub-id pub-id-type="pmcid">PMC6420699</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tintu</surname><given-names>AN</given-names></name><name name-style="western"><surname>le Noble</surname><given-names>FAC</given-names></name><name name-style="western"><surname>Rouwet</surname><given-names>EV</given-names></name></person-group><article-title>Hypoxia disturbs fetal hemodynamics and growth</article-title><source>Endothelium</source><year>2007</year><volume>14</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1080/10623320701746347</pub-id><pub-id pub-id-type="pmid">18080872</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramani</surname><given-names>M</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>WE</given-names></name><name name-style="western"><surname>Dell&#8217;Italia</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Ambalavanan</surname><given-names>N</given-names></name></person-group><article-title>Early exposure to hyperoxia or hypoxia adversely impacts cardiopulmonary development</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><year>2015</year><volume>52</volume><fpage>594</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2013-0491OC</pub-id><pub-id pub-id-type="pmid">25255042</pub-id><pub-id pub-id-type="pmcid">PMC4491135</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srivatsa</surname><given-names>B</given-names></name><name name-style="western"><surname>Hagan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Clark</surname><given-names>RH</given-names></name><name name-style="western"><surname>Kupke</surname><given-names>KG</given-names></name></person-group><article-title>Oxygenation factors associated with retinopathy of prematurity in infants of extremely low birth weight</article-title><source>J. Pediatr.</source><year>2022</year><volume>247</volume><fpage>46&#8211;52.e4</fpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2022.03.057</pub-id><pub-id pub-id-type="pmid">35427689</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lithopoulos</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Neonatal hyperoxia in mice triggers long-term cognitive deficits via impairments in cerebrovascular function and neurogenesis</article-title><source>J. Clin. Investig.</source><year>2022</year><volume>132</volume><fpage>e146095</fpage><pub-id pub-id-type="doi">10.1172/JCI146095</pub-id><pub-id pub-id-type="pmid">36136598</pub-id><pub-id pub-id-type="pmcid">PMC9663164</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reily</surname><given-names>C</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Renfrow</surname><given-names>MB</given-names></name><name name-style="western"><surname>Novak</surname><given-names>J</given-names></name></person-group><article-title>Glycosylation in health and disease</article-title><source>Nat. Rev. Nephrol.</source><year>2019</year><volume>15</volume><fpage>346</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1038/s41581-019-0129-4</pub-id><pub-id pub-id-type="pmid">30858582</pub-id><pub-id pub-id-type="pmcid">PMC6590709</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rigby</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>TW</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>MS</given-names></name></person-group><article-title>Oxygen participation in the in vivo and in vitro aging of collagen fibres</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1977</year><volume>79</volume><fpage>400</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(77)90171-1</pub-id><pub-id pub-id-type="pmid">588273</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappu</surname><given-names>P</given-names></name><name name-style="western"><surname>Salo</surname><given-names>A</given-names></name><name name-style="western"><surname>Myllyharju</surname><given-names>J</given-names></name><name name-style="western"><surname>Heino</surname><given-names>J</given-names></name></person-group><article-title>Role of prolyl hydroxylation in the molecular interactions of collagens</article-title><source>Essays Biochem.</source><year>2019</year><volume>63</volume><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1042/EBC20180053</pub-id><pub-id pub-id-type="pmid">31350381</pub-id><pub-id pub-id-type="pmcid">PMC6744578</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inability of low oxygen tension to induce chondrogenesis in human infrapatellar fat pad mesenchymal stem cells</article-title><source>Front. Cell Dev. Biol.</source><year>2021</year><volume>9</volume><fpage>703038</fpage><pub-id pub-id-type="doi">10.3389/fcell.2021.703038</pub-id><pub-id pub-id-type="pmid">34381784</pub-id><pub-id pub-id-type="pmcid">PMC8350173</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buckley</surname><given-names>CT</given-names></name><name name-style="western"><surname>Vinardell</surname><given-names>T</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>DJ</given-names></name></person-group><article-title>Oxygen tension differentially regulates the functional properties of cartilaginous tissues engineered from infrapatellar fat pad derived MSCs and articular chondrocytes</article-title><source>Osteoarthritis Cartilage</source><year>2010</year><volume>18</volume><fpage>1345</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2010.07.004</pub-id><pub-id pub-id-type="pmid">20650328</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howcroft</surname><given-names>TK</given-names></name><etal/></person-group><article-title>The role of inflammation in age-related disease</article-title><source>Aging</source><year>2013</year><volume>5</volume><fpage>84</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.18632/aging.100531</pub-id><pub-id pub-id-type="pmid">23474627</pub-id><pub-id pub-id-type="pmcid">PMC3616233</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowser</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JW</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name><name name-style="western"><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group><article-title>The hypoxia-adenosine link during inflammation</article-title><source>J. Appl. Physiol.</source><year>2017</year><volume>123</volume><fpage>1303</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00101.2017</pub-id><pub-id pub-id-type="pmid">28798196</pub-id><pub-id pub-id-type="pmcid">PMC5792095</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Triner</surname><given-names>D</given-names></name><name name-style="western"><surname>Shah</surname><given-names>YM</given-names></name></person-group><article-title>Hypoxia-inducible factors: a central link between inflammation and cancer</article-title><source>J. Clin. Investig.</source><year>2016</year><volume>126</volume><fpage>3689</fpage><lpage>3698</lpage><pub-id pub-id-type="doi">10.1172/JCI84430</pub-id><pub-id pub-id-type="pmid">27525434</pub-id><pub-id pub-id-type="pmcid">PMC5096825</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lun</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J</given-names></name></person-group><article-title>Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease</article-title><source>Front. Pharmacol.</source><year>2023</year><volume>14</volume><fpage>1045997</fpage><pub-id pub-id-type="doi">10.3389/fphar.2023.1045997</pub-id><pub-id pub-id-type="pmid">37201028</pub-id><pub-id pub-id-type="pmcid">PMC10187758</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorrello</surname><given-names>NV</given-names></name><etal/></person-group><article-title>Functional vascularized lung grafts for lung bioengineering</article-title><source>Sci. Adv.</source><year>2017</year><volume>3</volume><fpage>e1700521</fpage><pub-id pub-id-type="doi">10.1126/sciadv.1700521</pub-id><pub-id pub-id-type="pmid">28875163</pub-id><pub-id pub-id-type="pmcid">PMC5576878</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levenberg</surname><given-names>S</given-names></name><etal/></person-group><article-title>Engineering vascularized skeletal muscle tissue</article-title><source>Nat. Biotechnol.</source><year>2005</year><volume>23</volume><fpage>879</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1038/nbt1109</pub-id><pub-id pub-id-type="pmid">15965465</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Connell</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Within or without you? A perspective comparing in situ and ex situ tissue engineering strategies for articular cartilage repair</article-title><source>Adv. Healthc. Mater.</source><year>2022</year><volume>11</volume><fpage>2201305</fpage><pub-id pub-id-type="doi">10.1002/adhm.202201305</pub-id><pub-id pub-id-type="pmcid">PMC11468013</pub-id><pub-id pub-id-type="pmid">36541723</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ngo</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Vascular geometry and oxygen diffusion in the vicinity of artery-vein pairs in the kidney</article-title><source>Am. J. Physiol.-Ren. Physiol.</source><year>2014</year><volume>307</volume><fpage>F1111</fpage><lpage>F1122</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00382.2014</pub-id><pub-id pub-id-type="pmid">25209866</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Androjna</surname><given-names>C</given-names></name><name name-style="western"><surname>Gatica</surname><given-names>JE</given-names></name><name name-style="western"><surname>Belovich</surname><given-names>JM</given-names></name><name name-style="western"><surname>Derwin</surname><given-names>KA</given-names></name></person-group><article-title>Oxygen diffusion through natural extracellular matrices: implications for estimating &#8220;critical thickness" values in tendon tissue engineering</article-title><source>Tissue Eng. Part A</source><year>2008</year><volume>14</volume><fpage>559</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1089/tea.2006.0361</pub-id><pub-id pub-id-type="pmid">18377199</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendez-Romero</surname><given-names>O</given-names></name><name name-style="western"><surname>Ricardez-Garc&#237;a</surname><given-names>C</given-names></name><name name-style="western"><surname>Casta&#241;eda-Tamez</surname><given-names>P</given-names></name><name name-style="western"><surname>Chiquete-F&#233;lix</surname><given-names>N</given-names></name><name name-style="western"><surname>Uribe-Carvajal</surname><given-names>S</given-names></name></person-group><article-title>Thriving in oxygen while preventing ROS overproduction: no two systems are created equal</article-title><source>Front. Physiol.</source><year>2022</year><volume>13</volume><fpage>874321</fpage><pub-id pub-id-type="doi">10.3389/fphys.2022.874321</pub-id><pub-id pub-id-type="pmid">35444563</pub-id><pub-id pub-id-type="pmcid">PMC9013945</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures</article-title><source>Biotechnol. Bioeng.</source><year>2007</year><volume>97</volume><fpage>188</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1002/bit.21225</pub-id><pub-id pub-id-type="pmid">17054120</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>SF</given-names></name><name name-style="western"><surname>Buckley</surname><given-names>CT</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>DJ</given-names></name></person-group><article-title>Measuring and modeling oxygen transport and consumption in 3D hydrogels containing chondrocytes and stem cells of different tissue origins</article-title><source>Front. Bioeng. Biotechnol.</source><year>2021</year><volume>9</volume><fpage>591126</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2021.591126</pub-id><pub-id pub-id-type="pmid">34124013</pub-id><pub-id pub-id-type="pmcid">PMC8188180</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magliaro</surname><given-names>C</given-names></name><etal/></person-group><article-title>Oxygen consumption characteristics in 3D constructs depend on cell density</article-title><source>Front. Bioeng. Biotechnol.</source><year>2019</year><volume>7</volume><fpage>251</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2019.00251</pub-id><pub-id pub-id-type="pmid">31649925</pub-id><pub-id pub-id-type="pmcid">PMC6796794</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Preconditioning in neuroprotection: from hypoxia to ischemia</article-title><source>Prog. Neurobiol.</source><year>2017</year><volume>157</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2017.01.001</pub-id><pub-id pub-id-type="pmid">28110083</pub-id><pub-id pub-id-type="pmcid">PMC5515698</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsia</surname><given-names>CC</given-names></name></person-group><article-title>Respiratory function of hemoglobin</article-title><source>N. Engl. J. Med.</source><year>1998</year><volume>338</volume><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1056/NEJM199801223380407</pub-id><pub-id pub-id-type="pmid">9435331</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Responsive porous microcarriers with controllable oxygen delivery for wound healing</article-title><source>Small</source><year>2019</year><volume>15</volume><fpage>1901254</fpage><pub-id pub-id-type="doi">10.1002/smll.201901254</pub-id><pub-id pub-id-type="pmid">30997747</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>All-in-one bioactive properties of photothermal nanofibers for accelerating diabetic wound healing</article-title><source>Biomaterials</source><year>2023</year><volume>295</volume><fpage>122029</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2023.122029</pub-id><pub-id pub-id-type="pmid">36731368</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amberson</surname><given-names>WR</given-names></name><etal/></person-group><article-title>On the use of ringer-locke solutions containing hemoglobin as a substitute for normal blood in mammals</article-title><source>J. Cell. Comp. Physiol.</source><year>1934</year><volume>5</volume><fpage>359</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1002/jcp.1030050309</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buehler</surname><given-names>PW</given-names></name><name name-style="western"><surname>D&#8217;Agnillo</surname><given-names>F</given-names></name><name name-style="western"><surname>Schaer</surname><given-names>DJ</given-names></name></person-group><article-title>Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design</article-title><source>Trends Mol. Med.</source><year>2010</year><volume>16</volume><fpage>447</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2010.07.006</pub-id><pub-id pub-id-type="pmid">20708968</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bunn</surname><given-names>HF</given-names></name><name name-style="western"><surname>Esham</surname><given-names>WT</given-names></name><name name-style="western"><surname>Bull</surname><given-names>RW</given-names></name></person-group><article-title>The renal handling of hemoglobin</article-title><source>J. Exp. Med.</source><year>1969</year><volume>129</volume><fpage>909</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1084/jem.129.5.909</pub-id><pub-id pub-id-type="pmid">5778789</pub-id><pub-id pub-id-type="pmcid">PMC2138642</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Estep, T. N. <italic toggle="yes">Blood Substitutes and Oxygen Biotherapeutics</italic>, 287&#8211;292 (Springer International Publishing, 2022).</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>SD</given-names></name><name name-style="western"><surname>Elg</surname><given-names>F</given-names></name></person-group><article-title>Clinical effectiveness of hemoglobin spray (Granulox&#174;) as adjunctive therapy in the treatment of chronic diabetic foot ulcers</article-title><source>Diabet. Foot Ankle</source><year>2016</year><volume>7</volume><fpage>33101</fpage><pub-id pub-id-type="doi">10.3402/dfa.v7.33101</pub-id><pub-id pub-id-type="pmid">27829487</pub-id><pub-id pub-id-type="pmcid">PMC5102129</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Neuroprotective effects of combination therapy of regional cold perfusion and hemoglobin-based oxygen carrier administration on rat transient cerebral ischemia</article-title><source>Brain Res.</source><year>2020</year><volume>1746</volume><fpage>147012</fpage><pub-id pub-id-type="doi">10.1016/j.brainres.2020.147012</pub-id><pub-id pub-id-type="pmid">32652148</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gekka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Novel hemoglobin-based oxygen carrier bound with albumin shows neuroprotection with possible antioxidant effects</article-title><source>Stroke</source><year>2018</year><volume>49</volume><fpage>1960</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.118.021467</pub-id><pub-id pub-id-type="pmid">29991658</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Polynitroxylated PEGylated hemoglobin protects pig brain neocortical gray and white matter after traumatic brain injury and hemorrhagic shock</article-title><source>Front. Med. Technol.</source><year>2023</year><volume>5</volume><fpage>1074643</fpage><pub-id pub-id-type="doi">10.3389/fmedt.2023.1074643</pub-id><pub-id pub-id-type="pmid">36896342</pub-id><pub-id pub-id-type="pmcid">PMC9988926</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Hemoglobin-based oxygen carriers: where are we now in 2023?</article-title><source>Medicina</source><year>2023</year><volume>59</volume><fpage>396</fpage><pub-id pub-id-type="doi">10.3390/medicina59020396</pub-id><pub-id pub-id-type="pmid">36837597</pub-id><pub-id pub-id-type="pmcid">PMC9962799</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansman</surname><given-names>MMT</given-names></name><etal/></person-group><article-title>Hemoglobin-based oxygen carriers camouflaged with membranes extracted from red blood cells: Optimization and assessment of functionality</article-title><source>Biomater. Adv.</source><year>2022</year><volume>134</volume><fpage>112691</fpage><pub-id pub-id-type="doi">10.1016/j.msec.2022.112691</pub-id><pub-id pub-id-type="pmid">35581082</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toma</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Comparative in vivo effects of hemoglobin-based oxygen carriers (HBOC) with varying prooxidant and physiological reactivity</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0153909</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0153909</pub-id><pub-id pub-id-type="pmid">27097326</pub-id><pub-id pub-id-type="pmcid">PMC4838227</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fontes</surname><given-names>P</given-names></name><etal/></person-group><article-title>Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions</article-title><source>Am. J. Transplant.</source><year>2015</year><volume>15</volume><fpage>381</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1111/ajt.12991</pub-id><pub-id pub-id-type="pmid">25612645</pub-id><pub-id pub-id-type="pmcid">PMC5024042</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TMS</given-names></name></person-group><article-title>A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2015</year><volume>43</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3109/21691401.2014.964554</pub-id><pub-id pub-id-type="pmid">25297052</pub-id><pub-id pub-id-type="pmcid">PMC4268802</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TMS</given-names></name></person-group><article-title>Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2018</year><volume>46</volume><fpage>1349</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1080/21691401.2018.1476375</pub-id><pub-id pub-id-type="pmid">29873524</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Gynn</surname><given-names>M</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TMS</given-names></name></person-group><article-title>Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase</article-title><source>Artif. Cells Nanomed. Biotechnol.</source><year>2015</year><volume>43</volume><fpage>157</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.3109/21691401.2015.1035479</pub-id><pub-id pub-id-type="pmid">25961364</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chang</surname><given-names>TMS</given-names></name></person-group><article-title>Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant</article-title><source>Artif. Cells Blood Substit. Biotechnol.</source><year>2011</year><volume>39</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.3109/10731199.2011.581052</pub-id><pub-id pub-id-type="pmcid">PMC3584015</pub-id><pub-id pub-id-type="pmid">21574914</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dasmeh</surname><given-names>P</given-names></name><name name-style="western"><surname>Kepp</surname><given-names>KP</given-names></name></person-group><article-title>Bridging the gap between chemistry, physiology, and evolution: quantifying the functionality of sperm whale myoglobin mutants</article-title><source>Comp. Biochem. Physiol. Part A: Mol. Integr. Physiol.</source><year>2012</year><volume>161</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2011.07.027</pub-id><pub-id pub-id-type="pmid">21903173</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balcerek</surname><given-names>B</given-names></name><etal/></person-group><article-title>A broad diversity in oxygen affinity to haemoglobin</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>16920</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-73560-9</pub-id><pub-id pub-id-type="pmid">33037242</pub-id><pub-id pub-id-type="pmcid">PMC7547706</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gros</surname><given-names>G</given-names></name><name name-style="western"><surname>Wittenberg</surname><given-names>BA</given-names></name><name name-style="western"><surname>Jue</surname><given-names>T</given-names></name></person-group><article-title>Myoglobin&#8217;s old and new clothes: from molecular structure to function in living cells</article-title><source>J. Exp. Biol.</source><year>2010</year><volume>213</volume><fpage>2713</fpage><lpage>2725</lpage><pub-id pub-id-type="doi">10.1242/jeb.043075</pub-id><pub-id pub-id-type="pmid">20675540</pub-id><pub-id pub-id-type="pmcid">PMC2912754</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>M</given-names></name><etal/></person-group><article-title>Regulation of scaffold cell adhesion using artificial membrane binding proteins</article-title><source>Macromol. Biosci.</source><year>2017</year><volume>17</volume><fpage>1600523</fpage><pub-id pub-id-type="doi">10.1002/mabi.201600523</pub-id><pub-id pub-id-type="pmid">28233419</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro-Forero</surname><given-names>A</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>D</given-names></name><name name-style="western"><surname>L&#243;pez-Garriga</surname><given-names>J</given-names></name><name name-style="western"><surname>Torres-Lugo</surname><given-names>M</given-names></name></person-group><article-title>Immobilization of myoglobin from horse skeletal muscle in hydrophilic polymer networks</article-title><source>J. Appl. Polym. Sci.</source><year>2008</year><volume>107</volume><fpage>881</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1002/app.26289</pub-id><pub-id pub-id-type="pmcid">PMC2748953</pub-id><pub-id pub-id-type="pmid">19777086</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Hydrogel oxygen reservoirs increase functional integration of neural stem cell grafts by meeting metabolic demands</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>457</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-36133-8</pub-id><pub-id pub-id-type="pmid">36709345</pub-id><pub-id pub-id-type="pmcid">PMC9884236</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helmerhorst</surname><given-names>HJF</given-names></name><etal/></person-group><article-title>Metrics of arterial hyperoxia and associated outcomes in critical care*</article-title><source>Crit. Care Med.</source><year>2017</year><volume>45</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000002084</pub-id><pub-id pub-id-type="pmid">27763912</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>JPK</given-names></name><etal/></person-group><article-title>Artificial membrane-binding proteins stimulate oxygenation of stem cells during engineering of large cartilage tissue</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>7405</fpage><pub-id pub-id-type="doi">10.1038/ncomms8405</pub-id><pub-id pub-id-type="pmid">26080734</pub-id><pub-id pub-id-type="pmcid">PMC4557285</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunther</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kelman</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>JT</given-names></name><name name-style="western"><surname>Mason</surname><given-names>RP</given-names></name></person-group><article-title>Self-peroxidation of metmyoglobin results in formation of an oxygen-reactive tryptophan-centered radical</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>16075</fpage><lpage>16081</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.27.16075</pub-id><pub-id pub-id-type="pmid">7608169</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burmester</surname><given-names>T</given-names></name><name name-style="western"><surname>Weich</surname><given-names>B</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>S</given-names></name><name name-style="western"><surname>Hankeln</surname><given-names>T</given-names></name></person-group><article-title>A vertebrate globin expressed in the brain</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>520</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/35035093</pub-id><pub-id pub-id-type="pmid">11029004</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ascenzi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Neuroglobin: from structure to function in health and disease</article-title><source>Mol. Asp. Med.</source><year>2016</year><volume>52</volume><fpage>1</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2016.10.004</pub-id><pub-id pub-id-type="pmid">27825818</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>H</given-names></name><name name-style="western"><surname>Wakasugi</surname><given-names>K</given-names></name></person-group><article-title>Human neuroglobin functions as an oxidative stress-responsive sensor for neuroprotection</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>30128</fpage><lpage>30138</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.373381</pub-id><pub-id pub-id-type="pmid">22787149</pub-id><pub-id pub-id-type="pmcid">PMC3436268</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Neuroglobin protects the brain from experimental stroke in vivo</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>3497</fpage><lpage>3500</lpage><pub-id pub-id-type="doi">10.1073/pnas.0637726100</pub-id><pub-id pub-id-type="pmid">12621155</pub-id><pub-id pub-id-type="pmcid">PMC152321</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>17944</fpage><lpage>17948</lpage><pub-id pub-id-type="doi">10.1073/pnas.0607497103</pub-id><pub-id pub-id-type="pmid">17098866</pub-id><pub-id pub-id-type="pmcid">PMC1693852</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willemen</surname><given-names>NGA</given-names></name><etal/></person-group><article-title>Enzyme mediated alleviation of peroxide toxicity in self oxygenating biomaterials</article-title><source>Adv. Healthc. Mater.</source><year>2022</year><volume>11</volume><fpage>2102697</fpage><pub-id pub-id-type="doi">10.1002/adhm.202102697</pub-id><pub-id pub-id-type="pmcid">PMC11041527</pub-id><pub-id pub-id-type="pmid">35362224</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markhard</surname><given-names>AL</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>JG</given-names></name><name name-style="western"><surname>To</surname><given-names>T-L</given-names></name><name name-style="western"><surname>Mootha</surname><given-names>VK</given-names></name></person-group><article-title>A genetically encoded system for oxygen generation in living cells</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2022</year><volume>119</volume><fpage>e2207955119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2207955119</pub-id><pub-id pub-id-type="pmid">36215519</pub-id><pub-id pub-id-type="pmcid">PMC9618058</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Komatsu, T. <italic toggle="yes">Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics</italic>, 339&#8211;348 (Springer Berlin Heidelberg, 2013).</mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Komatsu</surname><given-names>T</given-names></name><name name-style="western"><surname>Ohmichi</surname><given-names>N</given-names></name><name name-style="western"><surname>Zunszain</surname><given-names>PA</given-names></name><name name-style="western"><surname>Curry</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsuchida</surname><given-names>E</given-names></name></person-group><article-title>Dioxygenation of human serum albumin having a prosthetic heme group in a tailor-made heme pocket</article-title><source>J. Am. Chem. Soc.</source><year>2004</year><volume>126</volume><fpage>14304</fpage><lpage>14305</lpage><pub-id pub-id-type="doi">10.1021/ja046022t</pub-id><pub-id pub-id-type="pmid">15521720</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapleton</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Microfluidic encapsulation of photosynthetic cyanobacteria in hydrogel microparticles augments oxygen delivery to rescue ischemic myocardium</article-title><source>J. Biosci. Bioeng.</source><year>2023</year><volume>135</volume><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/j.jbiosc.2023.03.001</pub-id><pub-id pub-id-type="pmid">36966053</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwangbo</surname><given-names>H</given-names></name><etal/></person-group><article-title>Photosynthetic cyanobacteria can clearly induce efficient muscle tissue regeneration of bioprinted cell-constructs</article-title><source>Adv. Funct. Mater.</source><year>2023</year><volume>33</volume><fpage>2209157</fpage><pub-id pub-id-type="doi">10.1002/adfm.202209157</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastinfard</surname><given-names>A</given-names></name><name name-style="western"><surname>Dalisson</surname><given-names>B</given-names></name><name name-style="western"><surname>Barralet</surname><given-names>J</given-names></name></person-group><article-title>Aqueous decomposition behavior of solid peroxides: effect of pH and buffer composition on oxygen and hydrogen peroxide formation</article-title><source>Acta Biomater.</source><year>2022</year><volume>145</volume><fpage>390</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2022.04.004</pub-id><pub-id pub-id-type="pmid">35405328</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>BK</given-names></name><name name-style="western"><surname>Sikes</surname><given-names>HD</given-names></name></person-group><article-title>Quantifying intracellular hydrogen peroxide perturbations in terms of concentration</article-title><source>Redox Biol.</source><year>2014</year><volume>2</volume><fpage>955</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2014.08.001</pub-id><pub-id pub-id-type="pmid">25460730</pub-id><pub-id pub-id-type="pmcid">PMC4215397</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krautschick</surname><given-names>I</given-names></name><name name-style="western"><surname>Krugmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Neuenfeld</surname><given-names>M</given-names></name></person-group><article-title>The effect of peroxides on the vascular endothelium of isolated pig aorta in vitro</article-title><source>Exp. Toxicol. Pathol.</source><year>1995</year><volume>47</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0940-2993(11)80286-1</pub-id><pub-id pub-id-type="pmid">7536500</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steg</surname><given-names>H</given-names></name><etal/></person-group><article-title>Control of oxygen release from peroxides using polymers</article-title><source>J. Mater. Sci. Mater. Med.</source><year>2015</year><volume>26</volume><fpage>207</fpage><pub-id pub-id-type="doi">10.1007/s10856-015-5542-z</pub-id><pub-id pub-id-type="pmid">26155978</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aleemardani</surname><given-names>M</given-names></name><name name-style="western"><surname>Solouk</surname><given-names>A</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>S</given-names></name><name name-style="western"><surname>Dehghan</surname><given-names>MM</given-names></name><name name-style="western"><surname>Moeini</surname><given-names>M</given-names></name></person-group><article-title>Silk-derived oxygen-generating electrospun patches for enhancing tissue regeneration: Investigation of calcium peroxide role and its effects on controlled oxygen delivery</article-title><source>Materialia</source><year>2020</year><volume>14</volume><fpage>100877</fpage><pub-id pub-id-type="doi">10.1016/j.mtla.2020.100877</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suvarnapathaki</surname><given-names>S</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>A</given-names></name><name name-style="western"><surname>Goulopoulos</surname><given-names>A</given-names></name><name name-style="western"><surname>Camci-Unal</surname><given-names>G</given-names></name></person-group><article-title>Oxygen-generating scaffolds for cardiac tissue engineering applications</article-title><source>ACS Biomater. Sci. Eng.</source><year>2023</year><volume>9</volume><fpage>409</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1021/acsbiomaterials.2c00853</pub-id><pub-id pub-id-type="pmid">36469567</pub-id><pub-id pub-id-type="pmcid">PMC11416866</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>3D printed polycaprolactone/beta-tricalcium phosphate/magnesium peroxide oxygen releasing scaffold enhances osteogenesis and implanted BMSCs survival in repairing the large bone defect</article-title><source>J. Mater. Chem. B</source><year>2021</year><volume>9</volume><fpage>5698</fpage><lpage>5710</lpage><pub-id pub-id-type="doi">10.1039/D1TB00178G</pub-id><pub-id pub-id-type="pmid">34223587</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khorshidi</surname><given-names>S</given-names></name><name name-style="western"><surname>Karkhaneh</surname><given-names>A</given-names></name><name name-style="western"><surname>Bonakdar</surname><given-names>S</given-names></name></person-group><article-title>Fabrication of amine-decorated nonspherical microparticles with calcium peroxide cargo for controlled release of oxygen</article-title><source>J. Biomed. Mater. Res. Part A</source><year>2020</year><volume>108</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1002/jbm.a.36799</pub-id><pub-id pub-id-type="pmid">31515881</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiekh</surname><given-names>PA</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Oxygen-releasing antioxidant cryogel scaffolds with sustained oxygen delivery for tissue engineering applications</article-title><source>ACS Appl. Mater. Interfaces</source><year>2018</year><volume>10</volume><fpage>18458</fpage><lpage>18469</lpage><pub-id pub-id-type="doi">10.1021/acsami.8b01736</pub-id><pub-id pub-id-type="pmid">29737151</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L</given-names></name><name name-style="western"><surname>Kang</surname><given-names>YJ</given-names></name></person-group><article-title>An oxygen-releasing device to improve the survival of mesenchymal stem cells in tissue engineering</article-title><source>Biofabrication</source><year>2019</year><volume>11</volume><fpage>045012</fpage><pub-id pub-id-type="doi">10.1088/1758-5090/ab332a</pub-id><pub-id pub-id-type="pmid">31315098</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdem</surname><given-names>A</given-names></name><etal/></person-group><article-title>3D bioprinting of oxygenated cell-laden gelatin methacryloyl constructs</article-title><source>Adv. Healthc. Mater.</source><year>2020</year><volume>9</volume><fpage>1901794</fpage><pub-id pub-id-type="doi">10.1002/adhm.201901794</pub-id><pub-id pub-id-type="pmcid">PMC7500045</pub-id><pub-id pub-id-type="pmid">32548961</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>J&#228;gers</surname><given-names>J</given-names></name><name name-style="western"><surname>Wrobeln</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferenz</surname><given-names>KB</given-names></name></person-group><article-title>Perfluorocarbon-based oxygen carriers: from physics to physiology</article-title><source>Pflug. Arch.</source><year>2021</year><volume>473</volume><fpage>139</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/s00424-020-02482-2</pub-id><pub-id pub-id-type="pmcid">PMC7607370</pub-id><pub-id pub-id-type="pmid">33141239</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="other">Winslow, R. M. <italic toggle="yes">Blood Substitutes.</italic> 5&#8211;16. (ed. Winslow, R. M.) (Academic Press, 2006).</mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Riess, J. G. &amp; Krafft, M. P. <italic toggle="yes">Blood Substitutes.</italic> p. 259&#8211;275 (ed. Winslow, R. M.) (Academic Press, 2006).</mixed-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>J</given-names></name><name name-style="western"><surname>Parkinson</surname><given-names>C</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>P</given-names></name></person-group><article-title>Factors affecting emulsion stability, and the HLB concept</article-title><source>J. Colloid Interface Sci.</source><year>1972</year><volume>41</volume><fpage>359</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/0021-9797(72)90122-1</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caballero-Aguilar</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Microencapsulation of growth factors by microfluidic system</article-title><source>MethodsX</source><year>2021</year><volume>8</volume><fpage>101324</fpage><pub-id pub-id-type="doi">10.1016/j.mex.2021.101324</pub-id><pub-id pub-id-type="pmid">34434839</pub-id><pub-id pub-id-type="pmcid">PMC8374335</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Bioinspired perfluorocarbon-based oxygen carriers with concave shape and deformable shell</article-title><source>Adv. Mater. Technol.</source><year>2022</year><volume>7</volume><fpage>2100573</fpage><pub-id pub-id-type="doi">10.1002/admt.202100573</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hester</surname><given-names>S</given-names></name><name name-style="western"><surname>Ferenz</surname><given-names>KB</given-names></name><name name-style="western"><surname>Eitner</surname><given-names>S</given-names></name><name name-style="western"><surname>Langer</surname><given-names>K</given-names></name></person-group><article-title>Development of a lyophilization process for long-term storage of albumin-based perfluorodecalin-filled artificial oxygen carriers</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><fpage>584</fpage><pub-id pub-id-type="doi">10.3390/pharmaceutics13040584</pub-id><pub-id pub-id-type="pmid">33923881</pub-id><pub-id pub-id-type="pmcid">PMC8073927</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>PX</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JW</given-names></name></person-group><article-title>Biodegradable polymer scaffolds with well-defined interconnected spherical pore network</article-title><source>Tissue Eng.</source><year>2001</year><volume>7</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1089/107632701300003269</pub-id><pub-id pub-id-type="pmid">11224921</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><etal/></person-group><article-title>Perfluorocarbon-encapsulated porphyrin-lipid nanoparticles as a photoactive pyroptosis inducer for cancer therapy</article-title><source>J. Biomed. Nanotechnol.</source><year>2023</year><volume>19</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1166/jbn.2023.3489</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sovacool</surname><given-names>BK</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Bazilian</surname><given-names>M</given-names></name></person-group><article-title>Climate change and industrial F-gases: a critical and systematic review of developments, sociotechnical systems and policy options for reducing synthetic greenhouse gas emissions</article-title><source>Renew. Sustain. Energy Rev.</source><year>2021</year><volume>141</volume><fpage>110759</fpage><pub-id pub-id-type="doi">10.1016/j.rser.2021.110759</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohn</surname><given-names>CS</given-names></name><name name-style="western"><surname>Cushing</surname><given-names>MM</given-names></name></person-group><article-title>Oxygen therapeutics: perfluorocarbons and blood substitute safety</article-title><source>Crit. Care Clin.</source><year>2009</year><volume>25</volume><fpage>399</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.ccc.2008.12.007</pub-id><pub-id pub-id-type="pmid">19341916</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnaud</surname><given-names>F</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>K</given-names></name><name name-style="western"><surname>Sieckmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Moon-Massat</surname><given-names>P</given-names></name></person-group><article-title>In vitro alteration of hematological parameters and blood viscosity by the perfluorocarbon: Oxycyte</article-title><source>Int. J. Hematol.</source><year>2016</year><volume>103</volume><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1007/s12185-016-1955-9</pub-id><pub-id pub-id-type="pmid">26886450</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toffaletti</surname><given-names>JG</given-names></name><name name-style="western"><surname>Wildermann</surname><given-names>RF</given-names></name></person-group><article-title>Use of turbidity-correction algorithm eliminates the effect of perflubron emulsion on CO-oximeter results</article-title><source>Clin. Chem.</source><year>2000</year><volume>46</volume><fpage>136</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1093/clinchem/46.1.136</pub-id><pub-id pub-id-type="pmid">10620590</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>E</given-names></name><name name-style="western"><surname>Janjic</surname><given-names>JM</given-names></name></person-group><article-title>Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxygen carriers</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>5569</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-84076-1</pub-id><pub-id pub-id-type="pmid">33692373</pub-id><pub-id pub-id-type="pmcid">PMC7946885</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Epstein</surname><given-names>PS</given-names></name><name name-style="western"><surname>Plesset</surname><given-names>MS</given-names></name></person-group><article-title>On the stability of gas bubbles in liquid gas solutions</article-title><source>J. Chem. Phys.</source><year>2004</year><volume>18</volume><fpage>1505</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1063/1.1747520</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heo</surname><given-names>H</given-names></name><etal/></person-group><article-title>Proliferative effects of nanobubbles on fibroblasts</article-title><source>Biomed. Eng. Lett.</source><year>2022</year><volume>12</volume><fpage>393</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1007/s13534-022-00242-y</pub-id><pub-id pub-id-type="pmid">36238371</pub-id><pub-id pub-id-type="pmcid">PMC9550906</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kheir</surname><given-names>JN</given-names></name><etal/></person-group><article-title>Bulk manufacture of concentrated oxygen gas-filled microparticles for intravenous oxygen delivery</article-title><source>Adv. Healthc. Mater.</source><year>2013</year><volume>2</volume><fpage>1131</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1002/adhm.201200350</pub-id><pub-id pub-id-type="pmid">23471884</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swanson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Borden</surname><given-names>MA</given-names></name></person-group><article-title>Injectable oxygen delivery based on protein-shelled microbubbles</article-title><source>Nano LIFE</source><year>2010</year><volume>01</volume><fpage>215</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1142/S1793984410000195</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farris</surname><given-names>AL</given-names></name><etal/></person-group><article-title>3D-printed oxygen-releasing scaffolds improve bone regeneration in mice</article-title><source>Biomaterials</source><year>2022</year><volume>280</volume><fpage>121318</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121318</pub-id><pub-id pub-id-type="pmid">34922272</pub-id><pub-id pub-id-type="pmcid">PMC8918039</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nirmalkar</surname><given-names>N</given-names></name><name name-style="western"><surname>Pacek</surname><given-names>AW</given-names></name><name name-style="western"><surname>Barigou</surname><given-names>M</given-names></name></person-group><article-title>On the existence and stability of bulk nanobubbles</article-title><source>Langmuir</source><year>2018</year><volume>34</volume><fpage>10964</fpage><lpage>10973</lpage><pub-id pub-id-type="doi">10.1021/acs.langmuir.8b01163</pub-id><pub-id pub-id-type="pmid">30179016</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vutha</surname><given-names>AK</given-names></name><etal/></person-group><article-title>A microfluidic device for real-time on-demand intravenous oxygen delivery</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2022</year><volume>119</volume><fpage>e2115276119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2115276119</pub-id><pub-id pub-id-type="pmid">35312360</pub-id><pub-id pub-id-type="pmcid">PMC9060478</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paknahad</surname><given-names>AA</given-names></name><name name-style="western"><surname>Zalloum</surname><given-names>IO</given-names></name><name name-style="western"><surname>Karshafian</surname><given-names>R</given-names></name><name name-style="western"><surname>Kolios</surname><given-names>MC</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>SS</given-names></name></person-group><article-title>Microfluidic nanobubbles: observations of a sudden contraction of microbubbles into nanobubbles</article-title><source>Soft Matter</source><year>2023</year><volume>19</volume><fpage>5142</fpage><lpage>5149</lpage><pub-id pub-id-type="doi">10.1039/D3SM00380A</pub-id><pub-id pub-id-type="pmid">37386867</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDannold</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vykhodtseva</surname><given-names>N</given-names></name></person-group><article-title>The effects of oxygen on ultrasound-induced blood-brain barrier disruption in mice</article-title><source>Ultrasound Med. Biol.</source><year>2017</year><volume>43</volume><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.ultrasmedbio.2016.09.019</pub-id><pub-id pub-id-type="pmid">27789044</pub-id><pub-id pub-id-type="pmcid">PMC5191922</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Ultrasound-triggered drug delivery for glioma therapy through gambogic acid-loaded nanobubble-microbubble complexes</article-title><source>Biomed. Pharmacother.</source><year>2022</year><volume>150</volume><fpage>113042</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2022.113042</pub-id><pub-id pub-id-type="pmid">35658212</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Henstock, J. R. &amp; El Haj, A. J. <italic toggle="yes">Mechanobiology</italic>, p. 275&#8211;296 (John Wiley &amp; Sons, Ltd, 2017).</mixed-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vukasovic</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bioreactor-manufactured cartilage grafts repair acute and chronic osteochondral defects in large animal studies</article-title><source>Cell Prolif.</source><year>2019</year><volume>52</volume><fpage>e12653</fpage><pub-id pub-id-type="doi">10.1111/cpr.12653</pub-id><pub-id pub-id-type="pmid">31489992</pub-id><pub-id pub-id-type="pmcid">PMC6869519</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufman</surname><given-names>MH</given-names></name><name name-style="western"><surname>Torgeson</surname><given-names>J</given-names></name><name name-style="western"><surname>Stegen</surname><given-names>JC</given-names></name></person-group><article-title>Metabolic multireactor: practical considerations for using simple oxygen sensing optodes for high-throughput batch reactor metabolism experiments</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><fpage>e0284256</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0284256</pub-id><pub-id pub-id-type="pmid">37432946</pub-id><pub-id pub-id-type="pmcid">PMC10335663</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Complex 3D microfluidic architectures formed by mechanically guided compressive buckling</article-title><source>Sci. Adv.</source><year>2021</year><volume>7</volume><fpage>eabj3686</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abj3686</pub-id><pub-id pub-id-type="pmid">34669471</pub-id><pub-id pub-id-type="pmcid">PMC8528415</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ameri</surname><given-names>AR</given-names></name><name name-style="western"><surname>Imanparast</surname><given-names>A</given-names></name><name name-style="western"><surname>Passandideh-Fard</surname><given-names>M</given-names></name><name name-style="western"><surname>Mousavi Shaegh</surname><given-names>SA</given-names></name></person-group><article-title>A whole-thermoplastic microfluidic chip with integrated on-chip micropump, bioreactor and oxygenator for cell culture applications</article-title><source>Anal. Chim. Acta</source><year>2022</year><volume>1221</volume><fpage>340093</fpage><pub-id pub-id-type="doi">10.1016/j.aca.2022.340093</pub-id><pub-id pub-id-type="pmid">35934343</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>S</given-names></name><etal/></person-group><article-title>Totally implantable oxygen generator (TIOG) for hypoxia and hypoxemia</article-title><source>IEEE Trans. Biomed. Eng.</source><year>2023</year><volume>70</volume><fpage>1380</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1109/TBME.2022.3217164</pub-id><pub-id pub-id-type="pmid">36282828</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="other">Scianmarello, N. et al. Oxygen generation by electrolysis to treat retinal ischemia. In <italic toggle="yes">2016 IEEE 29th International Conference on Micro Electro Mechanical Systems (MEMS)</italic>, 399&#8211;402 (2016).</mixed-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maharbiz</surname><given-names>M</given-names></name><name name-style="western"><surname>Holtz</surname><given-names>W</given-names></name><name name-style="western"><surname>Sharifzadeh</surname><given-names>S</given-names></name><name name-style="western"><surname>Keasling</surname><given-names>J</given-names></name><name name-style="western"><surname>Howe</surname><given-names>R</given-names></name></person-group><article-title>A microfabricated electrochemical oxygen generator for high-density cell culture arrays</article-title><source>J. Microelectromech. Syst.</source><year>2003</year><volume>12</volume><fpage>590</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1109/JMEMS.2003.815828</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safaee</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gravely</surname><given-names>M</given-names></name><name name-style="western"><surname>Roxbury</surname><given-names>D</given-names></name></person-group><article-title>A wearable optical microfibrous biomaterial with encapsulated nanosensors enables wireless monitoring of oxidative stress</article-title><source>Adv. Funct. Mater.</source><year>2021</year><volume>31</volume><fpage>2006254</fpage><pub-id pub-id-type="doi">10.1002/adfm.202006254</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonmezoglu</surname><given-names>S</given-names></name><name name-style="western"><surname>Fineman</surname><given-names>JR</given-names></name><name name-style="western"><surname>Maltepe</surname><given-names>E</given-names></name><name name-style="western"><surname>Maharbiz</surname><given-names>MM</given-names></name></person-group><article-title>Monitoring deep-tissue oxygenation with a millimeter-scale ultrasonic implant</article-title><source>Nat. Biotechnol.</source><year>2021</year><volume>39</volume><fpage>855</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1038/s41587-021-00866-y</pub-id><pub-id pub-id-type="pmid">33782610</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ochoa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Integrated sensing and delivery of oxygen for next-generation smart wound dressings</article-title><source>Microsyst. Nanoeng.</source><year>2020</year><volume>6</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/s41378-020-0141-7</pub-id><pub-id pub-id-type="pmid">34567658</pub-id><pub-id pub-id-type="pmcid">PMC8433317</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weidemann</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>RS</given-names></name></person-group><article-title>Biology of HIF-1<italic toggle="yes">&#945;</italic></article-title><source>Cell Death Differ.</source><year>2008</year><volume>15</volume><fpage>621</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1038/cdd.2008.12</pub-id><pub-id pub-id-type="pmid">18259201</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers</article-title><source>J. Hematol. Oncol.</source><year>2013</year><volume>6</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/1756-8722-6-19</pub-id><pub-id pub-id-type="pmid">23442817</pub-id><pub-id pub-id-type="pmcid">PMC3599349</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suh</surname><given-names>Y-A</given-names></name><etal/></person-group><article-title>Cell transformation by the superoxide-generating oxidase Mox1</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/43459</pub-id><pub-id pub-id-type="pmid">10485709</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Checa</surname><given-names>J</given-names></name><name name-style="western"><surname>Aran</surname><given-names>JM</given-names></name></person-group><article-title>Reactive oxygen species: drivers of physiological and pathological processes</article-title><source>J. Inflamm. Res.</source><year>2020</year><volume>13</volume><fpage>1057</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.2147/JIR.S275595</pub-id><pub-id pub-id-type="pmid">33293849</pub-id><pub-id pub-id-type="pmcid">PMC7719303</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granger</surname><given-names>DN</given-names></name><name name-style="western"><surname>Kvietys</surname><given-names>PR</given-names></name></person-group><article-title>Reperfusion injury and reactive oxygen species: the evolution of a concept</article-title><source>Redox Biol.</source><year>2015</year><volume>6</volume><fpage>524</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.08.020</pub-id><pub-id pub-id-type="pmid">26484802</pub-id><pub-id pub-id-type="pmcid">PMC4625011</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayevsky</surname><given-names>A</given-names></name></person-group><article-title>Brain NADH redox state monitored in vivo by fiber optic surface fluorometry</article-title><source>Brain Res. Rev.</source><year>1984</year><volume>7</volume><fpage>49</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/0165-0173(84)90029-8</pub-id><pub-id pub-id-type="pmid">6370376</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turrens</surname><given-names>JF</given-names></name><name name-style="western"><surname>Alexandre</surname><given-names>A</given-names></name><name name-style="western"><surname>Lehninger</surname><given-names>AL</given-names></name></person-group><article-title>Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria</article-title><source>Arch. Biochem. Biophys.</source><year>1985</year><volume>237</volume><fpage>408</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(85)90293-0</pub-id><pub-id pub-id-type="pmid">2983613</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>8785</fpage><pub-id pub-id-type="doi">10.1038/ncomms9785</pub-id><pub-id pub-id-type="pmid">26525216</pub-id><pub-id pub-id-type="pmcid">PMC4659941</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Targeted myoglobin delivery as a strategy for enhancing the sensitivity of hypoxic cancer cells to radiation</article-title><source>iScience</source><year>2020</year><volume>23</volume><fpage>101158</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2020.101158</pub-id><pub-id pub-id-type="pmid">32464594</pub-id><pub-id pub-id-type="pmcid">PMC7256644</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rouwkema</surname><given-names>J</given-names></name><name name-style="western"><surname>Khademhosseini</surname><given-names>A</given-names></name></person-group><article-title>Vascularization and angiogenesis in tissue engineering: beyond creating static networks</article-title><source>Trends Biotechnol.</source><year>2016</year><volume>34</volume><fpage>733</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2016.03.002</pub-id><pub-id pub-id-type="pmid">27032730</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Rapid regeneration of a neoartery with elastic lamellae</article-title><source>Adv. Mater.</source><year>2022</year><volume>34</volume><fpage>2205614</fpage><pub-id pub-id-type="doi">10.1002/adma.202205614</pub-id><pub-id pub-id-type="pmid">36120809</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niklason</surname><given-names>LE</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>JH</given-names></name></person-group><article-title>Bioengineered human blood vessels</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>eaaw8682</fpage><pub-id pub-id-type="doi">10.1126/science.aaw8682</pub-id><pub-id pub-id-type="pmid">33033191</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linville</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior</article-title><source>Biomaterials</source><year>2019</year><volume>190-191</volume><fpage>24</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.10.023</pub-id><pub-id pub-id-type="pmid">30391800</pub-id><pub-id pub-id-type="pmcid">PMC6289621</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinstlinger</surname><given-names>IS</given-names></name><etal/></person-group><article-title>Perfusion and endothelialization of engineered tissues with patterned vascular networks</article-title><source>Nat. Protoc.</source><year>2021</year><volume>16</volume><fpage>3089</fpage><lpage>3113</lpage><pub-id pub-id-type="doi">10.1038/s41596-021-00533-1</pub-id><pub-id pub-id-type="pmid">34031610</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Longitudinal in vivo imaging to assess blood flow and oxygenation in implantable engineered tissues</article-title><source>Tissue Eng. Part C Methods</source><year>2012</year><volume>18</volume><fpage>697</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1089/ten.tec.2011.0744</pub-id><pub-id pub-id-type="pmid">22435776</pub-id><pub-id pub-id-type="pmcid">PMC3427639</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brady</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Engineered tissue vascularization and engraftment depends on host model</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><fpage>1973</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-23895-2</pub-id><pub-id pub-id-type="pmid">36737618</pub-id><pub-id pub-id-type="pmcid">PMC9898562</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Connor</surname><given-names>C</given-names></name><name name-style="western"><surname>Brady</surname><given-names>E</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>KR</given-names></name></person-group><article-title>Engineering the multiscale complexity of vascular networks</article-title><source>Nat. Rev. Mater.</source><year>2022</year><volume>7</volume><fpage>702</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1038/s41578-022-00447-8</pub-id><pub-id pub-id-type="pmid">35669037</pub-id><pub-id pub-id-type="pmcid">PMC9154041</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baranski</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Geometric control of vascular networks to enhance engineered tissue integration and function</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>7586</fpage><lpage>7591</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217796110</pub-id><pub-id pub-id-type="pmid">23610423</pub-id><pub-id pub-id-type="pmcid">PMC3651499</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unagolla</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jayasuriya</surname><given-names>AC</given-names></name></person-group><article-title>Hydrogel-based 3D bioprinting: a comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives</article-title><source>Appl. Mater. Today</source><year>2020</year><volume>18</volume><fpage>100479</fpage><pub-id pub-id-type="doi">10.1016/j.apmt.2019.100479</pub-id><pub-id pub-id-type="pmid">32775607</pub-id><pub-id pub-id-type="pmcid">PMC7414424</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>P</given-names></name><name name-style="western"><surname>Kathuria</surname><given-names>H</given-names></name><name name-style="western"><surname>Dubey</surname><given-names>N</given-names></name></person-group><article-title>Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models</article-title><source>Biomaterials</source><year>2022</year><volume>287</volume><fpage>121639</fpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121639</pub-id><pub-id pub-id-type="pmid">35779481</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shang</surname><given-names>L</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Design of capillary microfluidics for spinning cell-laden microfibers</article-title><source>Nat. Protoc.</source><year>2018</year><volume>13</volume><fpage>2557</fpage><lpage>2579</lpage><pub-id pub-id-type="doi">10.1038/s41596-018-0051-4</pub-id><pub-id pub-id-type="pmid">30353174</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>R</given-names></name><etal/></person-group><article-title>Composable microfluidic spinning platforms for facile production of biomimetic perfusable hydrogel microtubes</article-title><source>Nat. Protoc.</source><year>2021</year><volume>16</volume><fpage>937</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-00442-9</pub-id><pub-id pub-id-type="pmid">33318693</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grebenyuk</surname><given-names>S</given-names></name><etal/></person-group><article-title>Large-scale perfused tissues via synthetic 3D soft microfluidics</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>193</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-35619-1</pub-id><pub-id pub-id-type="pmid">36635264</pub-id><pub-id pub-id-type="pmcid">PMC9837048</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>WC</given-names></name><etal/></person-group><article-title>Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair</article-title><source>Biomaterials</source><year>2015</year><volume>72</volume><fpage>138</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.08.050</pub-id><pub-id pub-id-type="pmid">26370927</pub-id><pub-id pub-id-type="pmcid">PMC4617784</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caballero Aguilar</surname><given-names>LM</given-names></name><name name-style="western"><surname>Silva</surname><given-names>SM</given-names></name><name name-style="western"><surname>Moulton</surname><given-names>SE</given-names></name></person-group><article-title>Growth factor delivery: defining the next generation platforms for tissue engineering</article-title><source>J. Control. Release</source><year>2019</year><volume>306</volume><fpage>40</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2019.05.028</pub-id><pub-id pub-id-type="pmid">31150750</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritger</surname><given-names>PL</given-names></name><name name-style="western"><surname>Peppas</surname><given-names>NA</given-names></name></person-group><article-title>A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs</article-title><source>J. Control. Release</source><year>1987</year><volume>5</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/0168-3659(87)90034-4</pub-id><pub-id pub-id-type="pmid">25356469</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brazel</surname><given-names>CS</given-names></name><name name-style="western"><surname>Peppas</surname><given-names>NA</given-names></name></person-group><article-title>Modeling of drug release from Swellable polymers</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2000</year><volume>49</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/S0939-6411(99)00058-2</pub-id><pub-id pub-id-type="pmid">10613927</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caballero Aguilar</surname><given-names>L</given-names></name><name name-style="western"><surname>Stoddart</surname><given-names>PR</given-names></name><name name-style="western"><surname>McArthur</surname><given-names>SL</given-names></name><name name-style="western"><surname>Moulton</surname><given-names>SE</given-names></name></person-group><article-title>Polycaprolactone porous template facilitates modulated release of molecules from alginate hydrogels</article-title><source>React. Funct. Polym.</source><year>2018</year><volume>133</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.reactfunctpolym.2018.09.016</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soltani Dehnavi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Molecular camouflage by a context-specific hydrogel as the key to unlock the potential of viral vector gene therapy</article-title><source>Chem. Eng. J.</source><year>2023</year><volume>477</volume><fpage>146857</fpage><pub-id pub-id-type="doi">10.1016/j.cej.2023.146857</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>KM</given-names></name></person-group><article-title>Hyperbaric oxygen-generating hydrogels</article-title><source>Biomaterials</source><year>2018</year><volume>182</volume><fpage>234</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.08.032</pub-id><pub-id pub-id-type="pmid">30142523</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><etal/></person-group><article-title>A reactive oxygen species scavenging and o2 generating injectable hydrogel for myocardial infarction treatment in vivo</article-title><source>Small</source><year>2020</year><volume>16</volume><fpage>2005038</fpage><pub-id pub-id-type="doi">10.1002/smll.202005038</pub-id><pub-id pub-id-type="pmid">33169516</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>